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ABSTRACT 
 
Characterization of the Bacteriophage Lambda Holin and Its Membrane Lesion. 
(August 2010) 
Jill Sayes Dewey, B.S. Louisiana State University 
Chair of Advisory Committee: Dr. Ryland Young 
 
Bacteriophage holins are a diverse group of proteins that are responsible for the 
spontaneous and specifically-timed triggering of host cell lysis.   The best-studied holin, 
S105 of phage lambda, is known to form lesions, or “holes”, in the inner membrane of  
E. coli which are large enough to allow the endolysin through to the periplasm.  S105 
has been studied extensively by both genetic and biochemical approaches; however, 
little is known about the mechanism of hole formation or the structure of the lambda 
holin and its inner membrane lesion.   
An in vitro system for reconstituting hole formation by S105 was developed in 
which liposomes containing a self-quenched fluorophore served as artificial cell 
membranes (1-2).  Upon delivery of solubilized S105 to the liposomes, an increase in 
fluorescence was observed, indicating that the fluorophore within the liposomes had 
escaped into the surrounding media via an S105-mediated hole in the membrane.  This in 
vitro system, which has been optimized in this work, has been a valuable biochemical 
tool for analysis and reconstitution of the pathway to S105 hole formation in the cell 
membrane.   
 iv 
Due to the difficulty associated with over-expression and purification of toxic 
membrane proteins, there are no solved structures of bacteriophage holins.  Sample 
preparation and experimental conditions for NMR spectroscopy were optimized and 
structural information about a lambda holin mutant protein was obtained.  Specifically, 
micellar contacts of transmembrane domain regions versus water contacts of the C-
terminal region, secondary structure, and backbone dynamics were determined. 
Cryo-electron microscopy was used to visualize the inner membrane lesions 
formed by phage holins S105, P2 Y, and T4 T.  Therefore, the large holes initially seen 
in cells expressing S105 are not specific to the lambda holin, nor to class I holins.   The 
S105 holes average ~340 nm (3), and are the largest membrane lesions ever observed in 
biology.  They are stable at their original size, and are not localized to a specific region 
of the membrane.  In addition, missense mutants of S105 were used to correlate hole 
size, protein accumulation, and lysis timing in a current model for the S105 hole 
formation pathway.      
 v 
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CHAPTER I 
 
INTRODUCTION TO BACTERIOPHAGE HOLINS 
 
 Bacteriophages, or just simply phages, are viruses that infect and kill bacterial 
cells.  During the infection process, phages inject their DNA into the host cell, and 
progeny virions are assembled within the bacterium.  To effect release of the virus 
particles, phages ultimately kill their host cells through a process called lysis.  For lysis 
to occur, the host bacterial cell wall, or peptidoglycan layer, must be compromised in 
some way.  The cell wall primarily serves to protect the intracellular contents, as well as 
maintain the overall shape of the cell (4), but during lysis, it is considered the barrier 
which keeps progeny virions from escaping the cell.  For double-stranded nucleic acid 
phages, lysis is accomplished by a “holin-endolysin” system, and this strategy is referred 
to as the classic lysis paradigm (5-7).  The endolysin, or lysozyme, is a murein-
degrading, soluble enzyme that is responsible for the destruction of the cell wall 
peptidoglycan layer (4, 8).  The holin, a membrane-bound protein which is credited with 
activating the endolysin, has roles in both membrane depolarization and precise timing 
of lysis (4, 9-10). 
 
 
 
 
____________ 
This dissertation follows the style of Proceedings of the National Academy of Sciences 
of the United States of America. 
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The Lambda Lysis Paradigm 
Lambda is a double-stranded DNA phage with a long, non-contractile tail, 
belonging to the order Caudovirales and family Siphoviridae. In terms of lysis, lambda 
uses the classic paradigm of a holin-endolysin system.  Within the genome, there are 
four separate lysis genes which comprise the lambda lysis cassette.  The genes are 
located just downstream of the late promoter PR′ in the following order: S (holin), R 
(endolysin), Rz, and Rz1 (Fig. 1.1). S has translational start sites at positions Met1 and 
Met3, which serve as the beginning residues of two separate proteins, S107 and S105, 
respectively (11) (Fig. 1.2).  S105 is the holin and functions in both permeabilization of 
the membrane and lysis timing (6, 10).  S107 is the antiholin and functions to inhibit 
hole formation by S105 (10).  R, the endolysin, is responsible for degradation of the 
peptidoglycan layer, or cell wall, immediately preceding host cell lysis (12) (Fig. 1.3).  
Rz and Rz1 are two separate proteins, despite the fact that the Rz1 reading frame is 
completely embedded within Rz, which function in destabilization of the outer 
membrane, and together they form a spanin complex (13).  
During lambda lysis, S105 accumulates and oligomerizes in the inner membrane, 
and R is made in the cytoplasm, beginning with late gene expression.  At a precisely-
scheduled time that is genetically programmed, S105 forms a hole, or lesion, in the inner 
membrane, which allows the endolysin to bypass the cytoplasmic membrane and access 
its substrate, the peptidoglycan layer (6) (Fig. 1.3).  Once R has degraded the cell wall,  
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Figure 1.1.  Lysis cassettes of bacteriophages lambda, 21, and P2.  The following lysis 
genes are downstream of the late promoter, PR′ (arrow): holin (green), endolysin 
(orange), Rz-equivalent (magenta), and Rz1-equivalent (yellow).  P2 has an additional 
gene, lysA (blue), which encodes the antiholin.   
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Figure 1.2.  Dual-start motif of the lambda S gene.  S encodes for two separate proteins: 
S107 (green), which is the antiholin, and S105 (blue), which is the holin.  S107, which 
has two additional residues at the N-terminus, is 107 amino acids long, and its 
translation begins with Met1. S105 is 105 amino acids long, and its translation begins on 
Met3. 
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the outer membrane becomes destabilized with the help of Rz and Rz1 (13), and lysis 
ensues. 
 
The Lambda Holin S105 
 The lambda holin gene product, S105, was first characterized by Altman et al. 
(1983) using two different models (9).  The first model system was maxicells, in which 
the holin and endolysin genes were expressed from plasmids, and the second system 
involved UV-irradiated, lambda-infected cells.  The results indicated the lambda holin 
gene product to be an 8.5 kDa protein (9).  Isopycnic sucrose gradients containing 
lysates of infected cells were used to show that S105 localized to the inner membrane of 
E. coli cells (9).  As shown in Figure 1.4, the lambda holin has three transmembrane 
domains (TMDs) which span the inner membrane of a bacterial cell (14).  The N-
terminus is located in the periplasm, and the C-terminus is located in the cytoplasm (14).   
In order to determine the correct topology of S105 within the membrane, genetic 
and biochemical approaches were used.  Random mutagenesis and site-directed 
mutagenesis were used to change single residues throughout the 105 amino acid protein 
(15-16).  Studies with these mutants indicated that amino acid substitutions within all 
three TMDs of S105 changed the apparent lysis time (14).  In fact, alanine at position 52, 
within the second TMD, was converted to both glycine and valine (14).  The resulting 
mutants had very different phenotypes: S105A52G caused lysis of its host early at 19 
minutes after induction; S105A52V, in contrast, did not cause lysis of its host at all and                    
 
 6 
 
 
 
 
Figure 1.3.  Model of holin-endolysin mechanism for lambda lysis.  The cell envelope is 
composed of three layers: the outer membrane (OM), the peptidoglycan layer or cell 
wall (CW), and the inner membrane (IM).  The holin (green) accumulates and 
oligomerizes in the inner membrane which has an associated pmf until the spontaneous 
time of triggering for hole formation (arrow).  The endolysin (orange) accumulates in the 
cytoplasm, then passes through the inner membrane via the holin lesion. 
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was considered a non-hole-forming S mutant (17). Additional experiments involved 
cysteine substitutions of single amino acids, which allowed for chemical accessibility 
studies of S105.  Specifically, the single Cys substitution alleles were expressed in cells 
so that inverted membrane vesicles (IMVs) and spheroplasts could be made and treated 
with the sulfhydryl-specific, membrane-impermeant reagent 4-acetamido-4′-
((iodoacetyl)amino)stilbene-2,2′-disulfonic acid, disodium salt, or IASD (14).  Three 
regions within the protein remained resistant to modification by IASD, and corresponded 
to the core regions of the predicted TMDs for S105 (14) (Fig. 1.4). 
   
S105 has two distinct functions. The lambda holin is an inner membrane protein that 
oligomerizes upon accumulation until it forms a lesion in the membrane at an allele-
specific time (9-10) (Fig. 1.3).  The first biochemical evidence of S oligomerization in 
the inner membrane of E. coli cells was with detection of S-lacZ fusion proteins which 
had been extracted from membranes and crosslinked (18).  Later, crosslinking data of 
DSP-treated membranes containing S105 demonstrated the presence of covalently-
linked oligomers up to 6-mers (7).   
In addition to hole formation, S105 has a second role in the timing of host lysis.  
In fact, S105 hole formation, which is due to a spontaneous, genetically-programmed 
triggering for lysis, has been characterized as the simplest biological clock (6).  
Although very little is known about the timing of phage lysis, it is considered extremely 
important from an evolutionary viewpoint.  Extremely early lysis, such as before the first  
 8 
 
 
Figure 1.4.  Three classes of holin proteins.  Class I holins (left) have three 
transmembrane domains (TMDs) and an N-out, C-in topology.  Class II holins (middle) 
have two TMDs and an N-in, C-in topology.  Class III holins (right) have one TMD and 
an N-in, C-out topology. 
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 virion phages are formed, would result in a non-productive infection.  In this particular 
case, the absence of progeny virions would prevent subsequent infection of host cells.  
Alternatively, very late lysis is wasteful because progeny virions are trapped within a 
host and unable to infect more cells for the production of additional phage.  Therefore, 
the tight scheduling of holin activity is essential for productive host cell lysis.  The best 
way to illustrate this point is to compare the mutants S105A52G and S105A52V, which have 
already been mentioned in terms of their different lysis phenotypes.  S105A52G lyses very 
early at 17 min, while S105A52V is non-lytic (17).  Both mutants are non-plaque-formers; 
however, the reasons for their non-productive phage infections are very different.  
S105A52G lyses too early for phage virions to be able to form, while S105A52V forms 
virions, but without lysis, is not able to release progeny. 
     A recent publication, featuring a modeling approach of phage-induced lysis, 
focuses on the inherent optimization of lysis timing by the lambda holin (19).  According 
to the authors, lambda lysis involves a two step nucleation event; the first nucleation 
event being the condensation of holin “rafts”, or inner membrane-associated aggregates 
of molecules, long before the time of lysis, and the second nucleation event, the 
formation of a hole within the holin raft.  The modeling approach of the inner membrane 
holin molecules was used to assess the efficiency of phage lysis.  The authors used 
variables to represent the holin interaction, the hole nucleation, the average lysis time, 
and the timing accuracy.   The conclusions derived by the nucleation theory suggested 
that lambda lysis timing is optimal and cannot be improved upon by modeling.  In fact,  
 10 
the authors were unable to improve the lysis timing accuracy when they changed the 
holin interaction variable (19).    
      
 The structure of the S105-mediated lesion in vivo. Wang et al. (2003) used cells 
induced for expression of the fusion protein R, the lambda endolysin, tethered to full-
length -galactosidase ( -Gal), to determine the approximate size of the S105-mediated 
lesion (20).  The hole formed by S105 was large enough to allow the R- -Gal fusion 
protein, an active tetrameric -Gal with a size larger than 480 kDa in mass, to bypass the 
inner membrane and degrade the cell wall, leading to host cell lysis (20).  Experimental 
evidence, including lysis curves and plaque assays, showed that the R- -Gal fusion was 
functional in lysis when expressed with the holin S105.  In addition, the authors used a 
combination of immunoblotting and gel filtration to demonstrate the accumulation of R-
-Gal in its full-sized and active conformation.  Therefore, this data suggests that the 
size of the lambda holin lesion is much larger than previously anticipated.  In fact, to 
accommodate the size of tetrameric -Gal, a protein that is 30 times the size of the 18 
kDa endolysin, the S105-mediated hole must be larger than any known transmembrane 
channel constructed of intracellular proteins (20). To date, the largest documented 
membrane lesions are formed by the cholesterol-dependent cytolysins, a family of 
proteins which form pores with diameters of ~30 nm (21-22).  
In addition to elucidating the large size of the holin lesion, Wang et al. (2003) 
also tested the R- -Gal fusion protein for lysis in a prematurely triggered system (20). 
Specifically, the energy poison cyanide was added to a growing culture of cells induced 
 11 
for expression of either R, or R- -Gal, with S105.  The results showed that R caused 
lysis as expected while R- -Gal did not.  In a separate experiment, R- -Gal was 
expressed with an early lysing mutant of S105, S105A52G, and was shown to cause 
efficient lysis.  The experimental evidence suggested that prematurely triggered lysis 
resulted in smaller membrane lesions than spontaneously formed holes (20).  
  
The structure of the lambda holin. Just as very little is known about the S105-mediated 
inner membrane hole, the same is true for the structure of the lambda holin in vitro.  
Historically, structural studies of holins have been very difficult because of the 
limitations during over-expression of toxic membrane proteins for purification purposes.  
Despite the challenges associated with large-scale purification of membrane proteins, 
Coomassie-blue detectable amounts of S were obtained with T7-based over-expression 
from a pET vector (23).  In fact, 50-fold over-production of protein was achieved during 
the first 10 minutes following IPTG induction of such expression systems (6). The 
purified protein was shown to be localized to the membrane and the protein could be 
extracted from the membrane with either nonionic or zwitterionic detergents.  An 
oligohistidine tag was incorporated within the sequence of S105 at position 94, and its 
presence was shown not to affect lysis timing or holin function (24). Before position 94 
was tested, numerous oligohistidine insertions throughout S105, including both the N- 
and C-termini, were constructed.  Most of the insertions changed the behavior of S105, 
sometimes even completely abolishing holin function.  The presence of a His6 tag 
allowed for successful purification of 1-3 mg protein per liter culture via immobilized 
 12 
metal affinity ion chromatography (IMAC) (2).  The ability to obtain purified S105 at 
relatively high levels for detergent-soluble membrane proteins, facilitated efforts to both 
study hole formation in vitro and determine the structure of the lambda holin.   
 Although there are currently no solved structures of holin proteins, either through 
X-ray crystallography or nuclear magnetic resonance (NMR), electron microscopy (EM) 
has been instrumental in obtaining structural information about detergent-purified S105. 
Savva et al. (2008) showed that S105 which was extracted from the membrane and 
purified in the presence of dodecyl maltoside (DDM) formed different oligomeric 
species, as evident from three separate gel permeation peaks (25).  This was in contrast 
to Empigen BB (EBB)-purified S105 which was present in only a single oligomeric 
species, and only one gel permeation peak, after purification.  The peak fractions from 
gel filtration of DDM-purified S105 were analyzed by EM, revealing the presence of 
ring-like structures which were present as monomers, dimers, and stacks of rings (Fig. 
1.5).  Single particle analysis of the rings showed that the majority had an inner diameter 
of 8.5 nm, an outer diameter of 23 nm, and a height of 4 nm, a height which is very 
similar to the thickness of the lipid bilayer (Fig. 1.5) (25).  Additional experiments were 
carried out to assess the accessibility of S105 in rings to proteolysis and chemical 
modification.  Unlike S105-associated inverted membrane vesicles (IMVs), which  
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Figure 1.5.   S105 rings in detergent.  (A) EM image of ring-like structures, positioned 
in top-down view (arrows), or side-view (boxes/circles).  Inset shows averages of the 
most common size classes for the rings.  (B) Reconstructions based on single-particle 
analysis of the class averages.  (C) The ring depth was similar to the depth of the lipid 
bilayer.   Reprinted with permission from Savva et al. (25). 
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proved to be sensitive to proteinase K at both the N- and C-termini, S105 rings allowed 
for digestion of the C-terminus only.  The authors suggested that the N-terminus in S105 
rings was resistant to protease activity because it was protected by the formation of 
stacks (25).  Similarly, the thiol-modification reagent, PEG-maleimide (PEG-mal), was 
used to further analyze the accessibility of strategically-positioned cysteines within S105 
rings.  It was determined that cysteines positioned at the termini were able to react with 
PEG-mal, whereas Cys51, which is positioned within the second TMD, was only 
accessible to PEG-mal after treatment with the detergent sodium dodecyl sulfate (SDS).  
These rings may represent the holes, or lesions, formed by S105 within the bilayer of the 
inner membrane just before host cell lysis, but additional in vivo studies of S105 holes 
are required to make this determination (25). 
  
Classification of Holin Proteins 
Holins have been classified into three groups based on size, number of TMDs, 
and topology (Fig. 1.4).  It should be noted that actual TMDs have been experimentally 
demonstrated for only a few holins, while the majority of TMDs are identified by 
prediction programs such as TM hidden Markov model (TMHMM) (6).  Class I holins, a 
group which includes S105, have three TMDs, an N-terminal periplasmic domain, and a 
C-terminal cytoplasmic domain (6-7) (Fig. 1.4).  This group is also classified as having 
members with 90-125 amino acids.  In addition to the lambda holin, other class I holins 
include, but are not limited to, the following: Y from phage P2, LydA from phage P1, 
and gp13 from phage P22.  Class II holins have two TMDs, cytoplasmic N- and C-
 15 
terminal domains, and 65-85 amino acid residues (4-5) (Fig. 1.4). Members of this group 
include S68 from phage 21 and gp17.5 from phage T7, among others.  Class III holins, a 
group which consists of T4 T as well as the holin proteins of all T4-related phages, have 
a single TMD, cytoplasmic N-terminus and periplasmic C-terminus, and share very few, 
if any, characteristics with other holins (7) (Fig. 1.4).  
Although both Y from bacteriophage P2 and S105 from lambda are class I 
holins, the proteins differ considerably from one another.  For instance, there is no 
detectable protein sequence similarity between the holin proteins. In addition, lambda S 
has a dual start motif, which contains two separate translation initiation sites, one for 
encoding S105 and the other for S107 (11) (Fig. 1.2).  P2 Y, on the other hand, encodes a 
single protein, and therefore, only has one translational initiation site. In fact, there is a 
separate, unrelated gene, lysA, downstream of Y that is believed to encode the antiholin 
of phage P2 (26) (Fig. 1.1). This describes a system very different from that of many 
lambdoid phages with one gene encoding both the holin and the antiholin, which are two 
proteins of opposing function, despite the fact that they only differ by two or three N-
terminal amino acids (27).  Additional lysis genes have been identified for P2, which 
include the endolysin K, and Rz/Rz1- equivalent genes lysB and lysC (26) (Fig. 1.1).   
The second class of bacteriophage holins includes two proteins which are not 
required for host cell lysis.  gp17.5 from phage T7 has been shown to effect sharp lysis 
in the context of the lambda phage, i.e. 17.5 expressed with lambda genes R, Rz, and Rz1 
(28).  Unlike the lambda holin S105, gp17.5 is not essential for host cell lysis.  It was 
shown that cells infected with T7 phage, which were deleted for the 17.5 gene, were still 
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able to lyse host cells; however, lysis occurred at a slightly delayed time compared to 
cells infected with T7 phage containing gene 17.5 (29).  The authors suggested that the 
reason why a 17.5 deletion mutant still lyses cells may be because there is another, not 
yet identified, T7 holin gene which is responsible for membrane depolarization (29).   
S2168 from phage 21 is another example of a class II holin that is not required for 
host lysis (Figs. 1.1, 1.4).  This protein forms small holes, termed “pinholes”, which are 
not large enough to accommodate the size of the phage 21 endolysin, R21 (30).  Because 
the holin does not provide a lesion for R21 to use to bypass the inner membrane, the 
phage must have another mechanism for host lysis. Indeed, this mechanism describes a 
second mode of lysis which serves as an alternative to the paradigm holin-endolysin 
lambda lysis system.  R21 is a Signal-Anchor-Release (SAR) endolysin which contains a 
signal sequence, directing it to the membrane and into the periplasm via the host Sec 
system (30-31) (Fig. 1.6).  Once the membrane is depolarized by S2168, the SAR 
endolysin is released from the membrane, undergoes refolding, and becomes 
catalytically active, allowing lysis (32).   
The members of holin classes I and II are extremely diverse in terms of their 
primary structure, however this is not the case for class III holins.  In fact, class III is 
comprised solely of T4 and T4-like phage holins (7).  T, the holin from phage T4, is very 
large when compared to the average size of other holins.  In fact, T is twice the size of  
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Figure 1.6.  Modes of action for SAR endolysins versus soluble endolysins.  (A) SAR 
endolysins are tethered to the membrane.  (B)  Depolarization of the membrane by the 
holin releases the SAR endolysin into the periplasm.  (C) Soluble endolysins accumulate 
in the cytoplasm, and (D) are released into the periplasm upon hole formation by the 
holin.  Reprinted with permission from Xu et al. (33).  Copyright (2004) National 
Academy of Sciences, U. S. A. 
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the 105 amino acid lambda S, with an impressive 218 residues (34).  In addition, T is 
largely hydrophilic in nature as it contains 49 acidic and basic amino acids (Fig. 1.4) 
(34).  This describes a characteristic that is not shared by other holins belonging to the 
first two classes, which are largely defined by TMDs consisting of predominately 
hydrophobic residues.  When T is expressed with the lambda lysis genes, R, Rz, and Rz1, 
it elicits sharp lysis at 20 min, showing that it is a functional holin within the lambda 
context (34).  Much like S105, T-mediated lysis timing has some genetic malleability, as 
evident from single missense changes within T resulting in a wide range of lysis times 
(35).   
Phage T4 is subject to a phenomenon known as lysis inhibition, or LIN (34, 36).  
Although lysis does not occur during LIN, the cell continues to experience secondary 
infections by T4 phage, and progeny virions continue to form.  Lysis will eventually 
happen if secondary infections, or superinfection events, stop occurring.  From an 
evolutionary viewpoint, LIN is believed to prevent the phage from releasing progeny 
into an environment that is host-deficient, which is just as disadvantageous as a non-
productive infection.  In a recent publication, it was shown that the periplasmic domains 
of T, the T4 holin, and RI, the T4 antiholin, are the major players in T4 lysis inhibition 
(37).  The authors used a construct consisting of a PhoA fusion to the RI C-terminal 
domain to show that the periplasmic domain harbors the antiholin character.  Similar 
constructs of the T C-terminal domain fused to PhoA were used to demonstrate 
interactions between the periplasmic domains of RI and T.  In addition, co-
immunoprecipitation experiments showed that RI and T form a complex (37).  Although 
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the data demonstrate that the interaction between T and RI is involved in LIN, it is clear 
that the mode of LIN is not the same as that demonstrated by the lysis effector and 
inhibitor pair for lambda, S105 and S107, respectively, since T and R1 do not share 
sequence similarity. 
 
Recent Advances in Lambdoid Phage Lysis 
 Phage 21 has a lysis cassette which is structured very similarly to the lysis 
cassette of lambda, with S21, R21, Rz21, and Rz121 genes downstream of the late promoter 
(Fig. 1.1). Although the two regions of these phages appear to be the same, S21 and R21 
are actually quite different than S  and R .  The former illustrate a second general type of 
holin-endolysin pathway, with the two major players being a pinholin and a SAR 
endolysin (30, 33).  S2168, the holin of phage 21, forms small holes and is thus referred 
to as a pinholin (30).  It has been studied extensively, with recent evidence indicating 
that topological dynamics of the protein affect its lysis behavior.  S2168 has two TMDs 
(Fig. 1.7); the first TMD was shown to be unnecessary for host cell lysis (31).  In fact, 
when all of the residues which comprise TMD1 were deleted, the resulting 44 residue 
protein was able to accumulate in the membrane and effect triggering for lysis by 
activating the endolysin R21.  Also, when the membrane was depolarized by the addition 
of DNP, S2168 TMD1 prematurely triggered, indicating that it had retained its holin 
activity.  With the addition of a highly charged RYIRS epitope tag on the N-terminus of 
S2168 (Fig. 1.7), TMD1 was prevented from exiting the membrane, as evident by the 
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Figure 1.7.  Sequences and topologies of lysis proteins. (A) The SAR domain sequences 
for R21and Lyz (yellow boxes).  S2168 has 2 TMDs (boxes), and TMD1 is a SAR 
domain.  (B) Topology of lambda antiholin S107 (a) and holin S105 (b), and 21 antiholin 
S2168 (c) and holin S2168(d) in the inner membrane. TMD1 of S21exits the membrane to 
the periplasm (e).  Reprinted with permission from Park et al. (31).  Copyright (2006) 
National Academy of Sciences, U. S. A. 
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lack of disulfide bond formation and resistance to proteases in this region of the protein, 
ultimately preventing topological dynamics of TMD1 and lysis (31).    
Phage 21 endolysin, R21, has been characterized as a SAR endolysin (30).  R21 
contains an N-terminal signal sequence which targets the protein to the membrane.  
After R21 exits the membrane, it becomes an active enzyme which can degrade the 
peptidoglycan layer of the bacterial cell envelope (Fig. 1.6).  Therefore, R21 can in fact 
function without the large hole-forming capability of the holin because the endolysin 
does not pass through the inner membrane lesion formed by the holin. In such a system, 
it may seem as though the holin does not play a role in lysis by SAR endolysins.  
However, it has been shown that S21 forms small holes, which depolarize the membrane, 
allowing the release of the SAR domain from the membrane (30).  It has been suggested 
that pinholins, such as S2168, may in fact represent an intermediate stage in the evolution 
of holin-endolysin systems. 
 Although pinholins require SAR endolysins, the converse is not true.  Phage P1, 
like 21, has a SAR endolysin, and was shown to effect host cell lysis in the absence of 
the holin, LydA.  Similarly to R21, P1 Lyz has an N-terminal TMD that requires the Sec 
system for processing (33).  
 
Review of Recent Holin Literature 
Although the focus of this chapter has been on lambda S105 thus far, it is worth 
noting that there has been progress in the identification and characterization of putative 
holin genes among various bacteriophages.  At the time of publication for the most 
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recent holin review in 2000, there were ~200 holins identified, with over 50 unrelated 
gene families (25).  In the years since this review, that number has increased 
significantly, so much so that a current search in Genbank for the term „holin‟ results in 
over 2000 protein sequences.  
Unfortunately, the current criterion used as a basis for holin identification has not 
been useful.  Many putative holins have been determined and characterized solely by 
their size, association with the membrane, or proximity to other lysis genes.  There are 
distinct criteria which should be met in order for a protein to be definitively identified as 
a holin.  The most important aspect of holin function is sharp host cell lysis upon 
membrane depolarization.  Biologically, sharp lysis indicates that there is a specific, 
genetically-programmed time for hole-formation to occur, and that time, which is 
referred to as the triggering event, is dependent upon the holin (38).  Before the 
triggering event, there is absolutely no effect on the membrane.  This was demonstrated 
by the “spinning bug experiment”, in which E.coli were tethered to a flagellar motor 
during expression of the lambda holin gene (38). The rotation of the cells, which was 
directly proportional to the proton motive force (pmf), stopped abruptly at the moment 
of lysis, but there was no decrease in flagellar velocity prior to triggering (38).  Sharp 
lysis is defined as a rapid decrease in culture turbidity or optical density (OD) after a 
growing cell culture has been induced for expression of both the holin and endolysin 
genes.  A slow decrease in optical density over a long time period is not characteristic of 
bacteriophage holin activity, but rather demonstrates a general deterioration of the 
membrane barrier, allowing endolysin to escape. To test potential holin proteins for 
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effecting sharp lysis, they must be induced along with the endolysin for expression, and 
the resulting lysis curve must show a dramatic, saltatory decrease in culture turbidity, as 
measured by A550.     
Holin activity can be further demonstrated by using an energy poison such as 
dinitrophenol (DNP) to de-energize the membrane of a growing culture that has been 
induced for holin expression.  For true holins, addition of an energy poison will cause a 
premature triggering event. Until the time of triggering for hole formation, the pmf 
serves as the only barricade to lesion formation, and once the membrane has been de-
energized by the addition of DNP, the cell lyses.  The list of criteria for testing potential 
holins also includes successful complementation of a strain containing all necessary 
phage lysis genes except the holin.  When a true holin is expressed at physiological 
levels in trans in a strain containing Sam7 (39), a nonfunctional lambda holin gene, it 
will effect sharp, saltatory lysis.    
   
Putative holins identified by sequence analysis. The genome of bacteriophage 15 
which infects Gram negative Salmonella enterica was recently sequenced (40).  
Comparative studies showed that regions of the 15 genome share homology with 
known lysis genes from other phages.  In particular, genes 23 and 24 were identified as 
putative holins, and gene 25 was designated as the endolysin (40). 
Srividhya and Krishnaswamy (2007) produced a database containing information 
about prophages, including current sequence information and known annotations (41).  
At the time of publication, the database had a total of 47 prophages which exhibited two-
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component lysis systems.  The authors pointed out that there are no prophage-encoded 
holin proteins which have been characterized biochemically or structurally.  The reasons 
were much the same as those described above for phage-encoded holins in that they are 
difficult to over-express and purify due to their toxicity.  The defective lambdoid 
prophage of Gram negative E. coli, DLP12, has the putative holin, essd, with two 
predicted TMDs as well as a dual-start motif (41).  Interestingly, this particular holin has 
96% homology to phage 21 holin, S21, the prototypical class II holin which encodes both 
a lysis effector and a lysis inhibitor.  DLP12 putative endolysin, ybcS, is also very 
similar to phage 21 endolysin, R21, in terms of both homology and presence of conserved 
SAR domains.  In fact, this represented the first reported prophage-encoded endolysin 
with an N-terminal SAR domain.  The authors concluded that DLP12 is only one of four 
prophages that have lysis cassettes similar to lambda, that is, containing not only the 
holin and endolysin, but also the Rz and Rz1-like genes,  which they referred to as the 
endopeptidase and the endopeptidase precursor, respectively (41). 
  
Phage holins of Gram negative hosts. The lysis genes of phage PM2, which infects 
Gram negative Pseudoalteromonas species, have been recently identified and 
characterized (42).  The lysis system appeared to be unique when its components were 
compared to other lysis genes.  For instance, gpk, a holin, has only a single TMD in its 
53 amino acid sequence, and is therefore the smallest holin thus far identified.  The 
topological characteristics of gpk do not allow it to fit into any of the current 
classifications for holin proteins.  The authors suggested that the cell wall is degraded by 
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cellular components, not necessarily by a phage-encoded endolysin (42). In this work, 
another protein, gpl, was identified as being necessary for outer membrane 
destabilization and disruption, functions that have been ascribed to the proteins Rz and 
Rz1 of phage lambda (13).  Mutations in both genes k and l resulted in turbid plaque 
formation as well as defective lysis.  In addition, DNP was added to phage PM2-infected 
cells and induced premature lysis, indicating that a holin was produced.  The authors 
were able to satisfy two of the three criteria for holin activity by successfully showing 
that gpk effects sharp, saltatory lysis and can be prematurely triggered with energy 
poisons, but they did not provide proof that gpk can complement a holin-deficient strain 
by effecting lysis in trans (42). 
The pneumococcal J-1 phage holin, EJh, has 85 residues and two TMDs, 
categorizing it as a class II holin with no dual start motif (Fig. 1.8a) (43).  Previously, 
EJh was shown to cause sharp lysis and complement Sam7 (44).  In a recent publication, 
authors created truncation mutants of EJh to determine which regions of the protein are 
important for holin activity.  Through experiments involving fluorescence quenching,   
and both circular and linear dichroism, they were able to show that the N-terminal 
transmembrane helix retained the active holin region.  In addition, fluorescence 
quenching was used to show oligomerization of the truncated protein (Fig. 1.8b).  Pore-
forming assays as well as atomic force microscopy (AFM) were used to assess the size 
of the holin-mediated lesion as ranging from 3 - 44 nm (43).  
 
 26 
Phage holins of Gram positive hosts. Putative lysis genes of Gram positive Oenococcus 
oeni phages, or oenophages, have recently been studied and reported.  One such gene is 
orf117 from Oenococcus oeni phage fOg44, which was initially identified as a putative 
holin because of its downstream location with respect to the endolysin gene through 
comparative genomic studies (45) (Fig. 1.9).  It was later shown to complement the non-
lytic lambda holin allele, Sam7, by inducing lysis upon expression in E. coli cells.  A 
second gene, orf163, shared homology with other putative holin genes, and therefore 
was tested for holin activity with Sam7 complementation.  Unlike orf117, orf163, a gene 
from fOg30, did not cause lysis when expressed in trans to the lysis-defective Sam7 
prophage (45).   
By genome comparison, the authors determined that the endolysins of these 
phages exhibited N-terminal domains which serve as signal peptides and are believed to 
be processed by the Sec system (45).  In light of the discovery that these phages contain 
secreted endolysins, it was suggested that the holin protein may in fact not be necessary 
for endolysin release from the cytoplasm.  In turn, orf163, which has holin-like features, 
but does not complement Sam7 with lytic activity, may still encode a holin that is 
responsible for membrane depolarization alone, instead of large hole formation, which is 
a characteristic of the pinholins.  To test this possibility, orf163 co-expressed with a 
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Figure 1.8.  Sequence and predicted topology of EJh.  (A) Protein sequence of EJh.  The 
predicted TMDs are rectangles.  (B) Predicted models of oligomerization and hole 
formation by EJh.  This research was originally published in The Journal of Biological 
Chemistry by Haro et al. (43).   © the American Society for Biochemistry and Molecular 
Biology.  Reprinted with permission. 
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Figure 1.9.  Lysis genes (green) for phages fOgPSU1, fOg44, fOg30, and phi10MC.  
Reprinted from Sao-Jose et al. (45), with permission from Elsevier. 
 
 
 
 
 
 
 
 
 
 
 29 
known SAR endolysin, such as R21, should effect lysis, while orf163 co-expressed with a 
soluble endolysin, such as R , would not cause lysis.  Similarly, orf163 and R21 should 
be susceptible to premature triggering with the addition of an energy poison, unlike 
orf163 expressed with R .  
The authors satisfied two of the three criteria for holin characterization of orf117 
with the demonstration of sharp lysis after gene expression and Sam7 complementation; 
however, experiments were not shown regarding premature lysis due to loss of the pmf, 
or protein expression levels.  The level of holin gene expression is an important 
consideration here, especially since the system being used involves Gram positive genes 
expressed in a Gram negative host, a situation which can lead to problems associated 
with poor gene expression (or complete lack of expression) as well as inadequate protein 
production, improper folding, and protein instability.  Additional experiments regarding 
further characterization of orf163 as a potential pinholin were also lacking.   
The lysis genes, specifically the holins, of 18 phages which infect Gram positive 
Lactococcus lactis have been recently reported and characterized (46).  The three 
lactococcal phage groups include c2, 936, and P335.  In the phages studied in this work, 
putative class I holins were identified for 936-like phages and c2-like phages, and 
putative class II holins were found in P335-like phages, based on sequence analysis.  
The authors focused on further characterization of the holin from a P335-like phage 
ul36, orf74B, by demonstrating that it could complement S, a lambda prophage which 
had been deleted for the holin gene, S, and effect lysis in E. coli.  In addition, the lysis 
time demonstrated by orf74B was very similar to that of wild-type S105 when it was 
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expressed in trans to S.  These experiments satisfied some criteria for characterizing 
orf74B as a true holin, but the authors did not demonstrate early lysis as a result of de-
energizing the membrane.  Labrie et al. (2004) addressed whether orf74B had a lysis 
clock component, given that it did not contain a dual start like S or other lactococcal 
phages by analyzing RNA isolated from phage-infected cells, and the results showed a 
delay in holin and endolysin gene expression (46).  It is worth noting that, in general, 
Gram positive candidates suffer from poor physiological systems, which often cause 
low, or no expression yields in Gram negative hosts.   
In a separate study, Yokoi et al. (2004) identified a two-component lysis system 
in the prophage gaY from Lactococcus gasseri JCM1131T through comparative studies 
(47).  The endolysin gene was designated lysgaY, and was shown to have lytic activity 
toward autoclaved L. gasseri JCM 1131 cells by zymogram analysis.  The holin was 
identified as HolgaY, based on its similarity to other holins.  holgaY, located upstream of 
lysgaY, encodes a 143 residue protein with a molecular mass of 15.7 kDa, which 
contains three putative TMDs.  When the authors over-expressed the construct 
p119gaY5, which contained both holgaY and lysgaYΔC1 under Plac control in E. coli, 
there was only a small decrease in culture turbidity, and this decrease occurred after 4 
hours of induction.  This result showed the effects of membrane toxicity, and not the 
effects of lysis due to holin activity (47). In fact, the authors were not able to 
demonstrate any of the necessary criteria for holin function, including expression of the 
holin gene product.   
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 Recently, some Staphylococcus phages have been characterized in terms of their 
lysis genes.  Gram positive Staphylococcus warneri M phage WMY has a two-
component lysis system which consists of a holin gene, holWMY, and an endolysin gene, 
lysWMY.  These genes and the proteins that they encode have been recently sequenced 
and analyzed (48).  HolWMY, located just upstream of LysWMY, has a molecular mass 
of 16kDa and is comprised of 148 amino acids (Fig. 1.10).  In addition, it has two 
putative TMDs, which is typical of class II holins, a basic N-terminus and a highly-
charged, acidic C-terminus (48). The authors stated that IPTG induction of HolWMY, 
under the control of the Plac promoter, resulted in decreased culture turbidity; however, 
because the data are not shown, it is difficult to conclude whether HolWMY satisfied the 
criteria for sharp, saltatory, and timely host cell lysis.  In fact, due to the absence of 
figures with lysis curves, it is not possible to evaluate the claim that HolWMY is a true 
holin.  A separate, recent publication suggested that Gram positive Staphylococcus 
aureus bacteria have two genes, cidA and lrgA, which may encode holin proteins (49).  
Specifically, in vitro and in vivo data showed that mutations in cidA disrupted biofilm 
formation and resulted in decreased lysis.  However, the authors did not present evidence 
that directly satisfied the criteria for testing holin function.  
 Gram positive Staphylococcus aureus phage P68 has the following lysis genes: 
two separate, putative holin genes, hol15 and hol12, and an endolysin gene, lys16 (50).  
Hol15 has three predicted TMDs, which is a characteristic of class I holin proteins, and 
Hol12 has two predicted TMDs, as is the case for class II holins.  Both holin genes, 
expressed from plasmids by an in vitro transcription-translation system, were able 
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to complement Sam7 upon expression in E.coli, and therefore exhibited holin lytic 
activity.  In addition, hol15 has a dual-start motif very similar to wild-type S and it is 
suggested that it encodes both a lysis effector (Hol15-90) and a lysis inhibitor (Hol15-
92).  In fact, when Hol15-92 was present with Lys16, lysis only occurred upon 
membrane depolarization, whereas, the presence of Hol15-90 together with Lys16 was 
enough to effect lysis.  Takac et al. (2005) addressed all of the before-mentioned 
essential criteria for testing holin activity, including demonstrating both sharp lysis and 
premature lysis by DNP, and characterized P68 Hol15 as a true holin protein (50).    
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CHAPTER II 
IN VITRO CHARACTERIZATION OF THE LAMBDA HOLIN* 
 
Part I: Protection of Holin Thiols During Protein Purification 
Holins are bacteriophage-encoded membrane proteins that control the length of 
the infection cycle.  They accumulate in the host membrane until a time programmed 
into their primary structure and then trigger to form lethal holes in the cytoplasmic 
membrane, allowing the phage-encoded lysozyme to degrade the cell wall.  Lysis ensues 
within seconds.  Holins are exquisitely malleable; that is, nearly every missense change 
alters the triggering time, either lengthening or shortening the infection cycle (11, 14, 
17). The best-characterized holin is S105, so designated because it is a 105 amino acid 
product of the S gene of bacteriophage lambda (6). The extensive genetic and molecular 
data available for S105 made it an attractive target for biochemical and structural 
characterization. In general, membrane proteins pose special difficulties for purification, 
including toxicity in typical bacterial over-expression systems, but S105 is especially 
 
 
 
 
___________ 
*Reprinted in part with permission from Dewey JS, Struck DK, & Young R (2009) Thiol 
protection in membrane protein purifications: a study with phage holins. Anal Biochem 
390(2):221-223. 
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 problematical because its biological function is to kill E. coli. Moreover, it was not 
possible to fuse purification tag domains to either the N or C termini without 
compromising function in vivo (24). Chemical accessibility studies showed that most of 
the S105 sequence is occupied by three TMDs (14), so there were limited options for 
placing an oligohistidine tag.  Ultimately, thirteen different positions within the S105 
sequence were tested for the ability to support lysis with normal kinetics, and one allele, 
S105 94, with GGHHHHHHGG inserted between residues 94 and 95, was obtained 
(24). Recombinant clones of S105 94 were constructed allowing the accumulation of 0.5 
- 1 mg of S105 94 per liter of induced over-expression culture (2). The subsequent 
purification of the extracted material involves immobilized metal affinity 
chromatography (IMAC), during which the protein is exposed to both detergent and 
divalent cations. Here, we report evidence that during extraction and purification, the 
S105 protein is damaged by covalent modification of its single cysteine sulfhydryl group 
Cys51 and document an approach for protection of this thiol using a reversible thiol-
specific reagent.  
 
Results 
Modification of Cys51 sulfhydryls during membrane extraction. For the purposes of 
examining holin-mediated hole formation in vitro, preparations were made of the 
parental protein S105 94, and also, as a control, S105 94A52V, a missense mutant that is 
blocked in hole-formation in vivo. The production and purification of both proteins were 
identical, except that the initial levels of the S105 94A52V protein in the induced lysates 
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were substantially higher (not shown).  The state of the Cys51 sulfhydryl in the purified 
preparations was assessed with Ellman‟s Reagent (5,5‟-dithiobis (2-nitrobenzoic acid; 
DTNB) (51) (Fig. 2.1). The results show that more than 90% of the sulfhydryls had been 
modified.  To determine when the cysteine modification was occurring, aliquots were 
removed at each step and treated with the sulfhydryl-specific PEGylation reagent, PEG-
OPSS.  The results clearly show that protein from the whole cell, lysate, and French 
press-disruption steps was fully PEGylated by PEG-OPSS (Fig. 2.2, lanes 1-6). This 
indicates that the Cys51 sulfhydryl group is accessible and unmodified through these 
steps.  Modification was first apparent in the concentrated membrane material, which 
had been collected by high-speed centrifugation, resuspended in membrane extraction 
buffer, and incubated overnight with agitation.  Quantification of the Western blot bands 
revealed that more than half of the S105 had been oxidized to intermolecular disulfides 
(double asterisk, Fig. 2.2), and about half of the remaining monomeric S105 was unable 
to react with the thiol-specific reagent PEG-OPSS at this stage of the purification (Fig. 
2.2, lanes 11 and 12).  The degree of modification increased in the final steps of IMAC 
purification, such that most, if not all, of the purified protein was modified (Fig. 2.2, 
lanes 13 and 14).  
 
Protection of Cys51 sulfhydryls from modification. To prevent non-specific 
modification of the Cys51 sulfhydryl group and also artifactual intermolecular disulfide 
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Figure 2.1.  Reaction of purified S105 with Ellman‟s Reagent, DTNB.  Reduced 
glutathione was the positive control, and cystine was the negative control.  25 mM 
samples of reduced glutathione, cystine, S105 94, and S105 94A52V were incubated with 
DTNB, and the absorbance of each of the samples at 412 nm, which indicated the 
presence of the reaction byproduct, was monitored to determine the state of the 
sulfhydryl groups in solution (52-53).  
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Figure 2.2.   PEGylation of S105 94A52V during the purification process.  Samples 
incubated in the presence (+) and absence (-) of PEG-OPSS include TCA precipitated 
whole cells (lanes 1 and 2), resuspended cells (lanes 3 and 4), French pressate (lanes 5 
and 6), clearing spin supernatant (lanes 7 and 8), resuspended membranes (lanes 9 and 
10), extraction spin supernatant (lanes 11 and 12), purified protein (lanes 13 and 14).      
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bond formation, we selected another thiol reagent, 2,2‟-dithiodipyridine (DTDP) (54), 
which was incorporated at a saturating concentration of 20 mM into the membrane 
extraction buffer.  This reagent is small, making it less likely to be sterically restricted 
from access to thiol groups and fully reversible with Tris(2-carboxyethyl) phosphine 
hydrochloride (TCEP)  (Fig. 2.3).  The purification was conducted exactly as before, 
except that after elution from the IMAC column, the protein was reduced with 10 mM 
TCEP.  PEGylation was again used to assess the degree of protection achieved, using the 
TCEP-insensitive thiol reagent PEG-maleimide.  The results show clearly that the 
purified protein can be PEGylated to completion (Fig. 2.4A).   
To demonstrate that this method may be applicable to other proteins with 
reactive thiol groups, DTDP-protection and PEGylation was carried out with a second 
protein, S2168G48Chis.  S2168 is the holin protein from the lambdoid phage 21 (55). 
Although it functions in the same two-component holin-endolysin lysis system as 
lambda S105, the two proteins have many differences.  S2168 has only two TMDs, and 
instead of sizable inner membrane lesions that allow passage of pre-folded proteins, it 
forms "pinholes" that cannot allow escape of endolysin (30).  S2168G48Chis is a non-lethal 
Cys-substitution mutant of the S21 holin.  When DTDP was incorporated in the 
membrane extraction buffer during S2168G48Chis purification, it reacted with the 
sulfhydryl side chain of Cys48.  Only after the reduction of the bond between DTDP and 
the Cys48 thiol group of purified S2168G48Chis, was the protein able to react with a second 
sulfhydryl-specific reagent, PEG-maleimide (Fig. 2.4B).      
 
S105 
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Figure 2.3.  Diagram of DTDP-protection method for S105.  Cys 51 thiol group reacts 
with DTDP during membrane extraction and remains bound until protein purification is 
complete.  The DTDP is removed by reaction with the reducing agent TCEP.  Successful 
protection is then determined by the ability of the thiol to react with sulfhydryl-specific 
PEG-mal.  
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Figure 2.4.  DTDP-protection of S105 (A) and S6821G48C (B).  Monomeric protein 
denoted by one asterisk (*); Dimeric protein denoted by two asterisks (**); PEGylation 
product denoted by an arrow.    
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Discussion 
Currently, there are a variety of thiol-specific reagents commercially available 
for modification of free sulfhydryl groups within proteins.  Some of these reagents have 
been used for thiol modification during protein purification in an effort to maintain free 
sulfhydryls (56-59).  However, thiol protection during the rigors of detergent extraction 
and IMAC purification of membrane protein has not been specifically addressed.  For 
the purposes of protecting the S105 Cys51 side chain during protein purification, we 
chose to use 2,2‟-dithiodipyridine, also known as 2,2‟-dipyridyldisulfide (PDS) or 2-PD 
(60). This reagent has been shown to react specifically and completely with thiols (54).  
In addition, it is considered stable under normal conditions, and has a broad, 
physiologically relevant pH range of 3.4 - 8.1 (54).  DTNB, or Ellman‟s Reagent, on the 
other hand, is only effective within the pH range of 7.8 – 10.4 (54).   Its utility as a thiol-
protecting agent stems from the reversibility of the thiopyridine-cysteine disulfide 
linkage by the non-volatile reducing agent TCEP, as illustrated in this work.  DTDP-
protection has been described here for two holins, S105 and S2168G48C, but it is our 
expectation that it may be generally useful for application to cysteine-containing 
membrane proteins, which characteristically require extended biochemical manipulation 
during purification.   
 
Materials and Methods 
Reagents. The Talon metal affinity resin was obtained from Clontech Technologies, Inc.  
PEGylation reagents, PEG-OPSS and PEG-maleimide (PEG-mal), were purchased from 
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Nektar and Creative Biochem Laboratories, respectively.  EmpigenBB (EBB) was 
purchased from Fluka.  The Western blotting supersignal detection kit was obtained 
from Pierce.  All remaining reagents were obtained from Sigma. 
The over-expression strain E. coli C43(DE3)tonA::Tn10 (61) was used for all 
protein production.  The S105 plasmids pETS105H94 and pETS105H94A52V have been 
described previously (2), except the vector used for pETS105H94 was pET30b (25).  For 
over-expression of S2168G48Chis, the plasmid pETS2168G48Chis, a derivative of the 
previously-described pETS2168his (31), was constructed by Quickchange site-directed 
mutagenesis replacing Gly48 with a cysteine residue.  pETS2168G48Chis contains an 
oligohistidine tag between residues 66 and 67 (31).  Antibodies directed against peptides 
which correspond to the C-termini of S105 94 (62), as well as S2168his (31), have been 
previously described.   
 
Purification of S105. The details of the over-production of S105 94 and S105 94A52V 
have been described (2); production of S2168G48Chis was done the same way.  Briefly, 
C43(DE3)tonA::Tn10 cells carrying the respective pET30b (or pET11a) derivatives were 
grown at 37 °C in batch cultures, induced with 1 mM IPTG at A550 = 0.6, harvested by 
centrifugation at 50 min (for S105 94) or 90 min (for S105 94A52V and S2168G48Chis) and 
stored at -20 °C.  Frozen cells from 2 L of induced culture were resuspended in lysis 
buffer (20 mM Tris, pH 7.9, 150 mM NaCl, 1 mM EDTA, 1 mM DTT, and 1 mM 
PMSF) and disrupted by passage through a 30 mL Aminco French pressure cell at 
16,000 psi.  A low-speed clearing spin at 8,000 rpm in a Sorvall SS-34 rotor was used to 
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remove unlysed cells and cellular debris from the sample.  The supernatant was 
centrifuged at 100,000 g for 1.5 h at 4 °C to collect the membranes.  The supernatant 
was removed, and the membranes were resuspended in membrane extraction buffer (20 
mM Tris, pH 7.9, 150 mM NaCl, 10 mM MgCl2, 1 mM PMSF, 1% (v/v) EBB).  The 
resuspended membranes were incubated with gentle shaking overnight at 4 °C and then 
centrifuged at 100,000 g for 1.5 h in a Ti 50.2 rotor at 4 °C to separate the solubilized 
material from the residual insoluble material.  
For protein purification, the supernatant was applied to a Talon metal affinity 
(Clontech Technologies, Inc.) column that had been washed with distilled H2O and 
equilibrated with buffer A (20 mM Tris, pH 7.9, 150 mM NaCl, 1% (v/v) EBB).  The 
flow-through was reapplied to the column after a brief wash with 10 column volumes of 
buffer A.  Thirty column volumes of buffer A, then five column volumes of low 
imidazole buffer (20 mM Tris, pH 7.9, 150 mM NaCl, 20 mM imidazole, and 1% (v/v) 
EBB) were used to wash the column after the second flow-through.  The protein was 
eluted in 5 aliquots, each equivalent to the bed volume, in a buffer containing 20 mM 
Tris, pH 7.9, 150 mM NaCl, 500 mM imidazole, and 1% (v/v) EBB.  The purity of the 
protein was assessed by Coomassie brilliant blue staining of a precast 16.5% Tris tricine 
criterion gel (Biorad) loaded with aliquots from the purification process, and protein 
concentration was calculated from A280, using  = 11,460 M-1 cm-1 for S105 94 and 
S105 94A52V.  For PEGylation and DTDP-protection experiments, detection of the 
protein required Western blotting with antibodies directed either against a peptide 
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corresponding to the C-terminus of S105 94 (62) or a peptide corresponding to the C-
terminus of S2168his (31).   
 
Assaying free thiols with Ellman’s reagent. Solutions of reduced glutathione, cystine, 
and purified S105 94 and S105 94A52V in TBS, pH 7.9 were prepared at final 
concentrations of 25 μM in a volume of 95 μl.  Five microliters of 10 mM DTNB 
(dissolved in ethanol) was added to the above solutions.  The samples were mixed by 
pipetting and incubated in the dark at room temperature for 30 min.  The concentrations 
of free sulfhydryls in the assay solutions were determined by the presence of the anionic 
byproduct TNB (  = 14,150 M-1cm-1 at 412 nm (51-52). 
 
Monitoring sulfhydryl state with PEG-OPSS. Ten to fifteen fresh transformant colonies 
of C43(DE3) tonA::Tn10 pETS105H94A52V (2) were used to inoculate a 200 ml LB 
culture supplemented with 100 g/ml ampicillin.  The culture was grown at 37 °C in a 
shaking waterbath and induced at A550 = 0.5 for 50 min.  An aliquot of the culture was 
removed at 25 min for a whole cell sample, and the remaining culture was harvested for 
purification.  
The expressed protein in the whole cell sample was precipitated with 
trichloroacetic acid (TCA).  Five milliliters of the induced culture was added to 5 mL of 
cold 11.1% (v/v) TCA, vortexed, and incubated on ice for 30 min.  The samples were 
centrifuged at maximum speed in a tabletop IEC clinical centrifuge at 4 °C for 15 min.  
The pellet was washed with 5 mL of cold acetone, vortexed, and centrifuged at 4 °C (see 
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above) for 15 min.  The pelleted protein was air-dried for ~15 min and resuspended in 1 
mL of PEGylation buffer (0.5 M Tris HCl, pH 7.0, 1% (w/v) SDS, 1 mM EDTA).  Two 
hundred microliters of the resuspended protein was combined with 10 L of 60 mM 
PEG-OPSS, incubated at room temperature for 30 min, treated with 1.4 mL of cold 
acetone for 10 min at -20 °C, and centrifuged at 14,000 rpm in a tabletop 
microcentrifuge for 15 min at 4 °C.  The supernatant was carefully removed and the 
pellet thoroughly air-dried.  The dry pellet was resuspended in non-reducing 2X protein 
sample buffer (0.5 mg/mL bromophenol blue in 0.25 M Tris, pH 6.8) and incubated at 
37 °C for 10 min, then analyzed by SDS-PAGE and immunoblotted with the appropriate 
antibodies.   
The harvested cells from the original culture were used for protein purification, 
and aliquots were removed after each step. The aliquots, which contained ~0.01 g of 
purified protein, were diluted by 10-fold into PEGylation buffer. Ten microliters of 60 
mM PEG-OPSS was added to each of the samples, and incubated at room temperature 
for 30 min.  The samples were combined with an equivalent volume of non-reducing 2X 
protein sample buffer and analyzed by SDS-PAGE, then immunoblotted with the 
appropriate antibodies.  
 
DTDP-protection. S105 94 was purified as previously described, except a saturating 
concentration of 20 mM 2,2‟-dithiodipyridine was included in the membrane extraction 
buffer. DTDP dissolved in the buffer only after the solution was incubated for a few 
minutes in a boiling waterbath, and the reagent remained in solution after the buffer 
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returned to room temperature. Membrane extraction was carried out overnight at room 
temperature instead of at 4 °C, to ensure that DTDP did not precipitate. After elution 
from the Talon metal affinity column and concentration determination by A280, the 
protein was treated with 10 mM TCEP to reduce the bond between DTDP and the S105 
Cys51 sulfhydryl (or Cys48 in S2168G48Chis).  TCEP was added to the purified protein at a 
final concentration of 10 mM, and the samples were mixed by pipetting, and incubated 
for 5 min at room temperature.        
The reduced protein was diluted 10-fold into PEGylation buffer. 14 L of 10 mM 
PEG-mal was added to ~50-150 ng of reduced S105 protein for the +PEG samples. The 
reactions were mixed by pipetting and incubated for 30 min at room temperature. 
Aliquots of the samples were diluted at least 20-fold with 2X protein sample buffer 
containing -mercaptoethanol. This dilution step was used to obtain samples with the 
appropriate protein concentrations for detection with the Supersignal West Femto 
Maximum Sensitivity Substrate (Pierce).  In addition, the 20-fold dilution was necessary 
to reduce the high reaction concentrations of PEG-mal before the samples were loaded 
onto a gel, so that the reagent would not affect the mobility of the proteins during 
electrophoresis.  The samples were boiled for 5 min, then analyzed by SDS-PAGE and 
immunoblotted with the appropriate antibodies.  The procedure for protection of 
S2168G48Chis was identical.   
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Part II: In Vitro Reconstitution of Hole Formation 
The lambda holin, S105, has been studied extensively in vivo by both genetic and 
biochemical means, including mutational analyses, chemical accessibility studies, and 
chemical crosslinking experiments (14-16).  These assays have proven to be invaluable 
in efforts to understand S105 form and function in the membrane; however, very little is 
known about the actual mechanism of hole formation.  Specifically, the steps that are 
required for oligomers of S to transition into holes, or lesions, in the inner membrane of 
bacterial cells, are unknown.  In vitro assays featuring purified S105 and artificial 
membranes are the ideal system to study the pathway to hole formation, especially given 
the variety of characterized holin mutants that are available.  For example, the extensive 
collection of early and late lysing S105 mutants (15-16) provide a system for relating in 
vivo lysis time to in vitro hole formation.  In addition, the S105 temperature-sensitive 
mutant, A55T (63), can be used to control the system with temperature changes, 
essentially turning hole formation “on” at permissive temperatures and “off” at non-
permissive temperatures.  Finally, the characterized non-hole-forming mutants of S105, 
including but not limited to A52V (16), can serve as valuable negative controls in such 
in vitro assays.    
The in vitro approach for studying hole formation is dependent upon the ability 
to purify the lambda holin in a functional state.  Previous research has indicated that 
during the purification procedure, the lambda holin is somehow being modified.  For  
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instance, attempts to label the Cys51 sulfhydryl group in detergent-solubilized, purified 
S105 were unsuccessful, whereas labeling in the membrane, with whole cell samples, 
was efficient (14).  In addition, preliminary in vitro calcein release experiments in which 
GroEL-solubilized, purified S was added to liposomes containing a quenched 
fluorophore, was inefficient.  A large increase in intensity was expected when the 
quenched calcein was released from the liposomes through the holin lesion.  However, 
Figure 2.5 shows that a large portion of the purified protein did not contribute to hole 
formation because there was only a small increase in fluorescence intensity after 
addition of S105.  We hypothesized that inefficient hole formation by the in vitro system 
can be partially explained by chemical damage of the purified protein at its cysteine 
sulfhydryl group (64), which results in an inactive form of S. This work describes the 
optimization of an in vitro assay for demonstrating S105-mediated hole formation using 
a cysteine-less S105 mutant and artificial membrane vesicles. 
 
Results 
Purified S105 thiol modification and in vitro hole formation. For the dye release 
assays, cys-less versions of S105 and S105A52V were used to avoid any modification of 
the protein thiols during membrane extraction and purification (64).  In an effort to find 
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Figure 2.5.  In vitro hole formation with GroEL-solubilized S105.  Purified S/GroEL 
complex was added to calcein-loaded liposomes.  Upon hole formation in these artificial 
membranes, there was an increase in fluorescence intensity for wild-type S105, but no 
increase for the non-hole-forming mutant, SA52V.  Triton X-100 is added at the end of the 
experiment to determine the maximum possible fluorescence. 
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a cys-less mutant which behaved similarly to the wild-type protein in terms of lysis, the 
single cysteine residue at position 51 of S105 was converted to several amino acids (Fig. 
2.6).  It was determined that C51A resulted in a missense change which had the least 
effect on lysis timing and was chosen for these studies.  Since S105C51A was chosen as 
the wild-type protein for in vitro assays, it was important to test the non-hole-forming 
A52V mutation in the same background.   Expression of S105C51A A52V, like S105A52V, 
did not cause lysis of cells, and therefore was used as the negative control for these 
experiments (Fig. 2.7).   
 
S105 hole formation in vitro. An in vitro fluorescence assay was used to study the 
mechanism of hole formation by S105 (1-2).  First, S105C51A was purified on Talon resin 
columns as previously described (see Chapter II, part I) in the presence of EBB 
detergent, then eluted in octylglucoside detergent.  The detergent was then dialyzed 
away overnight, and the precipitated protein was dissolved in 6M Guanidine-HCl.  400 
nm membrane vesicles containing the fluorophore, calcein, were made through extrusion 
of  L-a-phosphatidylcholine (PC), 1,2-Dioleoyl-sn-Glycero-3-[Phospho-rac-(1-glycerol)] 
(DOPG), and rhodamine-labeled phosphoethanolamine (PE) lipids.    Dye release assays 
were then carried out when the guanidine-solubilized S105 was diluted into a solution 
containing calcein-loaded liposomes (2).  Upon hole formation, the calcein was released, 
and an increase in fluorescence was monitored with an ISS Koala spectrofluorometer.  
As a negative control, the non-hole-forming mutant S105C51A A52V was also tested 
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Figure 2.6.  Lysis curves of initial S105 Cys51 missense mutants.  All strains tested 
were MC4100 tonA ( SR); some strains expressed wild-type or mutant holin in trans 
from the plasmid pS105.  The single cysteine residue of S105 was converted to 11 
different amino acids.  Only those mutants which lysed at a time similar to wild-type 
lysis are shown above: S105C51M (light blue), S105C51A (yellow), S105wt (dark blue), 
S105C51L (pink), S105C51I (black).  Controls include MC4100 tonA ( SR) expressing 
pSam7 (green), and MC4100 tonA ( SR) with no S105 plasmid (red).  
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Figure 2.7.  Lysis behavior of S105C51A A52V. All strains tested were MC4100 tonA 
( SR); some strains expressed wild-type or mutant holin in trans from the plasmid 
pS105. The following plasmids were expressed: pS105wt (black), pS105C51A (light blue), 
pS105A52V (dark blue), pS105C51A  A52V (green).  Controls include MC4100 tonA 
( SR) expressing pSam7 (orange), and MC4100 tonA ( SR) with no S105 plasmid 
(red).  
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with the dye release assay, and shown to cause very little, if any, increase in 
fluorescence when added to preformed calcein-loaded liposomes.  Surprisingly, the non-
functional truncation mutant S105 TM1 C51A, which lacks the first TMD and has antiholin 
character (65), caused intermediate fluorescence release (more than S105C51A A52V, but 
less than S105C51A) when added to liposomes in an end-point assay.  The results of the in 
vitro fluorescence assay showed an average value of ~30% dye release upon the addition 
of purified S105C51A to calcein-loaded vesicles (Fig. 2.8).   
The question remained as to why there was less than 100% fluorescence release 
for S105C51A.  To answer this question, it was important to determine how much of the 
purified S105 was actually associating with the liposomes.  For this purpose, sucrose 
gradients were used.  Purified S105C51A was incubated with liposomes and the protein-
lipid mixture was loaded onto a pre-formed four-step gradient, ranging from 0 - 80% 
(w/v) sucrose.  After the gradient was centrifuged at 100,000 g for 1 h at 4 °C, the lipid 
floated as expected and formed a tight band at the interface of 20% (w/v) sucrose and 
buffer (0% (w/v) sucrose) (Fig. 2.9).  To determine how much S105 was associated with 
the lipid, fractions were collected from the top of the gradient and analyzed by 
immunoblotting.  The results showed that the majority of S105 had formed large 
aggregates and were present in the most concentrated sucrose fractions, whereas only a 
small amount of S105 was present in the 0% (w/v) and 20% (w/v) sucrose fractions 
containing lipid (Fig. 2.9).  Therefore, it was concluded that since only a small fraction 
of purified S105 was actually associating with the vesicles, it stands to reason that there 
would not be 100% dye release from calcein-loaded liposomes in the in vitro assay. 
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Figure 2.8.  S105C51A in vitro hole formation results.  At times 0-200 sec, background 
intensity was established with liposomes in buffer.  At time 200 sec, purified S105 was 
added to the liposomes with constant stirring, and fluorescence change was observed.  
Triton X-100 was added to the liposomes to determine maximum fluorescence.  
S105C51A is shown in blue, and S105C51A  A52V is shown in pink.  The data shown is a 
representative result (the average increase after addition of S105C51A was ~30%). 
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Cryo-EM of liposomes incubated with S105C51A. Cryo-electron microscopy (Cryo-EM) 
was used to observe liposomes in the presence and absence of S105C51A.  The hypothesis 
was that if there was in fact hole formation occurring in the in vitro system, there would 
be evidence of lesions in the vesicles, as imaged by cryo-EM.  Liposomes were made as 
described and diluted appropriately for cryo-EM.  S105C51A was purified as described 
and added to pre-formed liposomes.  The samples, liposomes alone and liposomes 
incubated with S105C51A, were plunge-frozen on EM grids in liquid ethane, then viewed 
under liquid nitrogen temperatures with cryo- EM, as later described in Chapter IV (3).  
The liposomes were prepared by extrusion using a 400 nm pore filter, but when the 
vesicles were viewed with cryo-EM, it was apparent that the liposomes were not all 
unilamellar.  In fact, the majority of the liposomes were multilamellar (Fig. 2.10A).  This 
may partially explain why only a percentage of the total dye was released in the in vitro 
fluorescence assays.   Specifically, S105 hole formation would have only resulted in the 
release of calcein from the outermost layer of multilamellar liposomes, and any dye 
contained within interior liposomes would have remained trapped inside the vesicles in a 
quenched state.  In any case, when the two separate samples, liposomes alone and 
liposomes incubated with S105C51A, were compared with cryo-EM, there appeared to be 
no visible differences in the two samples (Fig. 2.10).  
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Figure 2.9.  Western blot detection of S105C51A from liposome flotation fractions.  Lane 
1: molecular weight marker; lanes 2-9: aliquots from eight successive fractions (400 l 
each) taken from the top to the bottom of the gradient after centrifugation.  
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Figure 2.10.  Cryo-EM images of liposomes in the absence (A) and presence (B) of 
S105C51A.  
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Discussion 
 A completely in vitro system with purified lambda holin and artificial membrane 
vesicles, would be the ideal system for determining the pathway to hole formation by 
S105.  Such a system, with purified S105 being delivered to liposomes, which released a 
fluorescent signal upon hole formation, was implemented (1-2)  In this assay, S105, the 
functional lambda holin, was shown to cause hole formation when added to pre-formed 
liposomes, and the non-functional lambda holin mutant, S105A52V, did not cause hole 
formation.  
In this work, efforts were made to optimize the in vitro hole formation assay.  
Incremental advances were made in the optimization of the system.  Specifically, using a 
cysteine-less version of the lambda holin that had been solubilized in guanidine prior to 
its addition to membrane vesicles resulted in increased fluorescence release, compared to 
cysteine-containing S105 solubilized with GroEL, indicating more efficient hole 
formation for the former.  It became clear, however, that there were some remaining 
obstacles within the system.  First, sucrose gradient results indicated that the majority of 
the purified protein was not associating with the liposomes.  Instead, the protein 
appeared to form higher-order structures which were present with the most dense 
sucrose fractions after centrifugation instead of floating with the lipid.  Second, cryo-EM 
analysis of the liposomes indicated that the vesicles were multilamellar instead of 
unilamellar.  As a result, the fluorescence within the interior vesicles of a multilamellar 
liposome would not be released upon hole formation in the outermost layer.  Finally, 
S105 TM1 C51A, which is a non-functional mutant of the lambda holin, caused 
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fluorescence release when added to calcein-loaded liposomes in an end-point assay.  
This may reflect the ability of this truncated protein, with two TMDs, to insert efficiently 
within the membrane vesicles and cause leakage of the liposome contents. 
 
Materials and Methods 
Reagents. Lipids L-a-phosphatidylcholine (PC), 1,2-Dioleoyl-sn-Glycero-3-[Phospho-
rac-(1-glycerol)] (DOPG), rhodamine-labeled phosphoethanolamine (PE), and 
cholesterol were purchased from Avanti Polar Lipids.  Calcein, Empigen BB (EBB) and 
6M guanidine HCl were obtained from Sigma.  Octylglucoside (OG) was purchased 
from Anatrace.  Lipid extrusion was carried out with a Liposofast extruder from Avestin.  
Fluorescence readings were done with an ISS Koala dual-excitation spectrofluorometer. 
 
Protein purification. All protein samples used with the in vitro assay were purified as 
previously described (25, 64), except the protein was exchanged from Empigen BB 
detergent into octylglucoside detergent during Talon purification.  Once the protein was 
bound to the Talon resin, and washed with Buffer A (20 mM Tris pH 7.8, 150 mM NaCl, 
1 % (v/v) EBB), ~50 column volumes of Buffer B (20 mM Tris pH 7.8, 150 mM NaCl, 
1.4 % (w/v) OG) were passed over the column.  The remaining purification buffers were 
the same as previously described except they contained 1.4 % (w/v) OG instead of other 
detergents.     
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Liposome preparation. PC (4.9 mg), DOPG (2.1 mg), and cholesterol (0.7 mg) 
dissolved in ethanol were combined in a glass tube with 0.5 % (v/v) rhodamine PE, 
mixed, and dried with N2 gas to form a thin film on the interior walls of the glass tube.  
The tube was left in a dessicator for at least 1 hour to completely dry the lipids.  The 
dried lipids were then resuspended in 1 mL of 75 mM calcein, vortexed for ~5 min, and 
centrifuged briefly to bring all contents to the bottom of the tube.  The lipids were passed 
through a 400 nm pore filter using a Liposofast extruder 21 times, then applied to a 
preparative Sepharose gel filtration column.  The large orange-colored band from the 
void volume was collected because it contained the calcein-loaded liposomes.  The 
unincorporated calcein and remaining lipid material were eluted later and discarded. 
 
Sucrose gradient. Liposomes were made as described in the previous section, with the 
following exceptions.  Dried lipids were resuspended in 1X TBS, pH 7.8.  Gel filtration 
was not used to remove unincorporated calcein since no calcein was added to the dried 
lipid mixture.  Sucrose solutions were made in 1X TBS buffer at the following 
concentrations (w/v): 20%, 60%, and 80%.  Guanidine-solubilized S105 (4 M) and 
liposomes (1.75 mg/ml) were combined in 1X TBS buffer in a final volume of 400 l,  
and incubated at room temperature for 5 min.  The liposome-protein mixture was 
combined with 400 l 60% (w/v) sucrose, making the final concentration 30% sucrose.  
The sucrose gradient was made by carefully layering the following solutions from 
bottom to top in an ultracentrifuge tube: 600 l of 80% (w/v) sucrose, 800 l of 30% 
(w/v) sucrose (containing liposomes and protein), 1.2 ml 20% (w/v) sucrose, and 600 l 
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1X TBS buffer.  The tubes were centrifuged at 49,000 rpm (~100,000 g) for 1 hour in a 
Beckman TLS55 ultracentrifuge rotor at 4 °C.  A visible pink band indicating the 
rhodamine-labeled lipid present in the liposomes was localized to the buffer/20% (w/v) 
sucrose interface.  Fractions were collected from the gradient, top to bottom, in 400 l 
aliquots, and aliquots from each fraction were used for SDS-PAGE and immunoblotting. 
  
In vitro dye release assay. Purified S105C51A and S105C51A A52V, eluted in 1.4% (w/v) 
OG, were dialyzed overnight against 1X TBS buffer (20 mM Tris pH 7.8, 150 mM 
NaCl) containing 1 ml Biobeads (Sigma).  The proteins were removed from the dialysis 
cassettes the following day and spun down in an Eppendorf tube at 13,000 rpm in a 
tabletop microcentrifuge for 10 min.  The precipitates, containing the proteins in the 
absence of detergent, were resuspended in 6 M guanidine HCl.  The concentrations of 
the protein samples were determined by an A280 scan (  = 11,460 M-1 cm-1).   
A 2.5 ml glass cuvette with a small stir bar was used to house the sample within 
the spectrofluorometer (ISS).  Two milliliters of liposomes in 1X TBS were added to the 
cuvette at a final concentration of 43.75 g/ml.  The cuvette was placed in the sample 
compartment of the fluorometer, and the magnetic stirrer was enabled.  The absorbance 
and emission wavelengths, 490 nm and 520 nm respectively, were set according to the 
values used for the fluorophore calcein.  The slow kinetics setting over a time period of 
~ 10 min was used for data acquisition.  Once a steady background was established 
indicating the stability of the liposomes (i.e. no leaking calcein, which would cause the 
fluorescence to increase over time), 47 mol purified S105C51A was added to the 
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liposomes in buffer.  The change in fluorescence intensity after protein addition was 
monitored until the intensity flatlined.  Then, 1% Triton X-100, a detergent which 
solubilizes membrane vesicles, was added to the liposomes to obtain a value for 
maximum fluorescence.  The experiment was repeated as described for S105C51A A52V.  
The experiment was also repeated at varying liposome:protein ratios in an effort to 
optimize the assay.   
 GroEL solubilization and delivery of S105 was carried out as previously 
described (1). 
 
In vitro calcein release endpoint assay.  Protein and liposome concentrations were the 
same as for in vitro dye release assays.  Purified protein was added to the bottom of a 5 
ml Eppendorf tube and 2 ml of liposomes in buffer were pipetted directly into the tube 
so that the contents were mixed immediately.  The tube was incubated for at least 5 min 
at RT, then the sample was moved to a cuvette and single-point intensity readings were 
taken with the ISS Koala spectrofluorometer.  Ten microliters of 10% (v/v) Triton X-100 
was added to the sample, and another single-point intensity reading was taken for the 
sample to determine maximum fluorescence.   
 
Cryo-EM. Five microliters of a mixture of liposomes and purified S105C51A were applied 
to C-FLAT (CF-4/2-2C) or home-made lacey carbon-coated grids that had been glow-
discharged just prior to use. Grids were then plunge-frozen in ethane using an FEI 
Vitrobot. Specimens were observed in an FEI Tecnai G2 F20 TEM equipped with a 
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GATAN Tridiem GIF-CCD using zero-loss imaging and low-dose conditions with 
typical doses of 5-10 e-/Å2 per image. A GATAN 626 cryo-holder was used for all 
experiments (3).  
 65 
CHAPTER III 
NMR STUDIES OF A LAMBDA HOLIN MUTANT 
  
Structural information for the lambda holin would be extremely valuable for 
determining the mechanism of hole formation.  For example, a solved structure would 
inform investigators of protein subunit interactions, helical packing, and TMD 
interaction with lipid or lumen.  However, due to the difficulties associated with over-
expression and purification of membrane proteins, there are very few solved structures 
of such proteins (64).  In fact, there are currently no solved structures of bacteriophage 
holins, either by x-ray crystallography or nuclear magnetic resonance (NMR) 
spectroscopy.  In collaboration with Dr. Christian Hilty and Youngbok Lee (Chemistry 
Department, Texas A&M University), we sought to solve the NMR solution structure of 
the bacteriophage lambda holin protein mutant, S105 TM1 C51A.  This holin truncation 
mutant lacks the first TMD and lacks any Cys residues where oxidative damage could 
occur during preparation.  It was used for structural studies because it is small and 
relatively non-toxic to the membrane, can be produced in large quantities, and remains 
soluble for weeks at 4 °C. S105 TM1 contains only two TMDs, and is thought to mimic 
the canonical lambda antiholin, S107, in the membrane (65).  Both S107 and S105 TM1 
delay hole formation when expressed in trans to S105 (65), and therefore are considered 
to be functionally relevant proteins.  In addition, the structure of the holin-antiholin 
complex would likely mimic holin-holin interactions.  
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NMR has become a prominent method for solving membrane protein structures.  
Until recently, x-ray crystallography was considered the optimal method because there 
were restrictive protein size limitations with NMR (66). This is especially problematical 
for membrane proteins because in the purified form, they are embedded within detergent 
micelles, which adds considerably to the overall protein mass.  The experiment which 
was specifically designed to overcome the NMR size restrictions is called Triple 
Resonance Optimized Spectroscopy (TROSY) (66). TROSY allows for large proteins to 
be analyzed via NMR with the same resolution as would be possible for small proteins.  
Large protein samples usually have significant interfering transverse relaxation, which 
can reduce the overall signal and cause broad, poorly-resolved peaks.  TROSY filters out 
the interfering signals so that only the true signal, and none of the transverse relaxation, 
contributes to the overall signal (66).  Therefore, the resulting peaks are narrow and 
well-resolved, as would be the case with small protein samples.    
 
Results 
Assessing the behavior of the lambda holin for NMR. Before beginning structure 
determination of the lambda holin, it was important to first assess whether the conditions 
required for NMR were suitable for the protein.  After determining that the holin mutant 
S105 TM1 and the cys-less variant, S105 TM1 C51A, were successfully over-expressed and 
purified at the acceptable concentration for NMR (~1 mM), the sample was subjected to 
a range of temperatures that would be required for obtaining the necessary spectra.  In 
addition, there was extensive optimization of sample conditions, which included buffer 
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composition, pH, and selection of detergent micelles for protein solubility.  These 
preliminary experiments were carried out with unlabeled S105 TM1 C51A, and with buffers 
containing the detergents SDS or DDM, at pH ranging from 6.0 to 7.8, and temperatures 
of 15 - 35 °C.  The resulting 1D spectrum suggested that SDS would be an appropriate 
detergent for S105 TM1 structure determination, and lowering the pH may improve the 
peak resolution (Fig. 3.1).  The DDM spectrum contained less well-resolved peaks, as 
well as variations due to temperature changes (Fig. 3.2).  In fact, when [2H][15N] labeled 
S105 TM1 was analyzed under the same conditions, there were more detectable peaks for 
the protein in DDM when tested at the lower temperature of 15 °C, as compared to the 
increased temperature of 35 °C (Fig. 3.3).  The 2D spectrum of [2H][15N] labeled 
S105 TM1 in SDS proved to be very promising indeed.  The spectrum had 92 well-
resolved peaks, each one corresponding to a single amino acid within the protein, which 
has a total of 92 residues. From this spectrum, preliminary assignments for some of the 
peaks were made, specifically the 13 glycine residues and the single tryptophan residue 
which have distinct chemical shifts (Fig. 3.4). 
 In an effort to screen additional detergents for NMR studies of the holin mutant, 
the [2H][15N] S105 TM1 originally prepared in SDS and DDM was exchanged into 
buffers containing the detergents dodecyl phosphocholine (DPC) and  
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Figure 3.1.  1D spectra of unlabeled S105 TM1 C51A in SDS micelles at varying 
temperatures.  (A) Sample pH of 7.8; (B) Sample pH of 6.0.  
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Figure 3.2.  1D spectrum of unlabeled S105 TM1, pH 7.8, in DDM micelles at varying 
temperatures.  
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Figure 3.3. 2D spectra of [2H][15N] labeled S105 TM1 in DDM micelles at varying 
temperatures. The following temperatures were used: 35 °C (A) and 15 °C (B). 
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lauryldimethylamine-oxide (LDAO) by gel permeation chromatography.  The 2D 
spectrum of [2H][15N] labeled S105 TM1 in DPC micelles showed most of the amino acid 
peaks, but indicated sample degradation due to the presence of two additional tryptophan 
peaks (Fig. 3.5A).  The protease degradation was verified by analyzing the sample with a 
Coomassie-stained gel and immunoblotting with an antibody that specifically recognizes 
the C-terminus of the S protein (Fig. 3.5B,C).  Regardless of the protease degradation for 
the samples in DPC and LDAO detergents, it was apparent that the overall distribution 
of peaks in the DPC spectrum was much broader than the pattern of peaks in the SDS 
spectrum (Fig. 3.6), which provides clues as to the state of the protein.  A protein which 
is folded properly will have a broader distribution of residue peaks, whereas an unfolded 
species will exhibit a narrower spectrum.  Therefore, it was determined that SDS, an 
ionic detergent considered to be harsh, may in fact cause the protein to be unfolded, and, 
despite the fact that it provided promising preliminary data, it should not be used for 
additional studies.  Instead, LDAO, a detergent which has successfully been used in the 
NMR solution structure determination of other membrane proteins, such as Mistic (67) 
and VDAC-1 (68), and resulted in a broad spectrum for S105 TM1 similar to DPC, was 
chosen for future experiments.   
 
Testing the functionality of S105 TM1 C51A.  The remaining NMR results were carried out 
with the cys-less version of S105 TM1 so as to avoid any modification of the thiol at 
Cys51 during purification (see Chapter II) (64).  The functionality of this particular  
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Figure 3.4.  2D spectrum of [2H][15N] labeled S105 TM1 in SDS micelles at 35 °C (A).  
The 13 glycine residues are circled in red and the single tryptophan is circled in blue. 
The amino acid sequence of S105 TM1 (B).  The oligohistidine tag is underlined; the 
glycines are in red, and the tryptophan is in blue.  
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Figure 3.5.  NMR sample degradation.  2D spectrum of [2H][15N] labeled S105 TM1 in 
DPC micelles (A).  Coomassie-stained gel of samples used for NMR (B).  Western blot 
of samples used for NMR, detected with an antibody directed against the C-terminus of 
S105 (C).  Lanes in gel and blot are as follows: (1) molecular weight marker, (2) 
unlabeled S105 TM1 in SDS, (3) [2H][15N] labeled S105 TM1 in DDM, (4) [2H][15N] 
labeled S105 TM1 in SDS, (5) [2H][15N] labeled S105 TM1 in LDAO.  
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Figure 3.6.  2D spectra of [2H][15N] S105 TM1 in SDS (A) and DPC micelles (B).  The 
dotted lines and arrows indicate the overall distribution of peaks.  
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mutant was tested for inhibition of the full-length cys-less lambda holin by first 
constructing a strain containing a lysogen with S105C51A.  When the cys-less lambda 
holin mutant, S105C51A, is present on the prophage, and S105 TM1 C51A is expressed in 
trans from a plasmid, lysis is inhibited (Fig. 3.7).  The solved structure of this particular 
protein, because it resembles the holin S105 in form, and functions like the antiholin 
S107, would be invaluable toward efforts to elucidate the mechanism of hole formation.    
 
Three dimensional NMR of [
2
H][
15
N][
13
C] labeled S105 TM1 C51A.   Nuclear Overhauser 
Effect Spectroscopy, or NOESY, was used for many of the experiments described in this 
work.  NOESY allows for detection of protons within the same amino acid, protons on 
sequential residues, and protons that are not linked through bonds, but rather close in 
space (69).  The first successful NMR run with triple-labeled protein yielded two 
continuous fragments of assigned residues.  Using NOESY, it was clear that one 
fragment had significant contacts with the detergent micelle, and therefore should be in 
one of the transmembrane segments (70) (Fig. 3.8).  In fact, the peaks belonging to those 
particular residues, with their associated chemical shifts, were ultimately assigned to the 
third TMD of the holin.  The second fragment lacked these same micellar contacts, but 
instead had significant interactions with water, indicating that this region must be either 
at the termini or in the loop region between the two TMDs (70) (Fig. 3.9).  These peaks 
were assigned to the C-terminal tail region, which is believed to have very little ordered 
structure and is non-essential (17, 71-72). 
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Figure 3.7.  Functional test of S105 TM1 C51A.  The curves correspond to the following 
strains (“ ” indicates prophage and “p” indicates plasmid): S105C51A + pS105 TM1, 
purple; S105C51A + pS105 TM1 C51A, green; S105 + pS105 TM1, red; S105C51A + 
pSam7, black; S105 + pS105 TM1 C51A, orange; S105 + pSam7, blue.  
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Figure 3.8.  NOESY spectrum of residues within TMD3.  The red box indicates contacts 
with the micelle (70).  
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Figure 3.9.  NOESY spectrum of residues in the C-terminus.  The red box indicates 
contacts with water (70).   
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 Transverse Relaxation Optimized Spectroscopy, or TROSY, was also used in this 
work, in an effort to filter transverse relaxation from the overall signal and improve peak 
resolution (66).  Figure 3.10A shows the TROSY spectrum for [2H][15N][13C]-labeled 
S105 TM1 C51A in LDAO micelles.  Some of the peaks were distinct and well-resolved, 
but others were close to one another, making it difficult to determine where one peak 
ended and the next began (Fig. 3.10B).  In an effort to better resolve the peaks 
throughout the entire protein, improvements were made to the sample preparation.  First, 
the question of sample quality was addressed.  For these experiments, the optimal 
concentration of protein was 1 mM (or ~10 mg/ml for S) in a volume of at least 250 l.  
Although this seems simple enough for soluble proteins, this was not so easy to 
accomplish with a toxic membrane protein.  Nonetheless, the purification method was 
marginally streamlined and the buffer conditions were optimized so as to produce the 
highest concentration of protein possible.  Secondly, non-distilled D2O was used for all 
remaining experiments to ensure that deuteration levels remained high.  Finally, and 
perhaps most importantly, higher field magnets, with extremely sensitive cryoprobes, 
were used for future experiments, resulting in more peaks and better resolved peaks.  Dr. 
Christian Hilty and Youngbok Lee used the Varian 800 MHz spectrometer with triple 
resonance probe and the Bruker 800 MHz NMR spectrometer with cryoprobe for 
collecting data from a number of experiments, including: 2D-TROSY-HSQC, 3D- 
HNCA, 3D-NOESY, 3D-HNCACB, 3D-HNCO, 3D-HN(CA)CO, 3D-HN(CO)CA, 
1H15N heteronuclear NOE, and T1/T2 relaxation.  These experiments resulted in the  
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Figure 3.10.  TROSY spectra of [2H][15N][13C] labeled S105 TM1 C51A in LDAO 
micelles.  (A) The entire spectrum; the blue box indicates the region zoomed-in for panel 
B; (B) close-up view of region with poorly-resolved peaks.  
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assignment of 85 out of the total 92 amino acid residues (70).  Chemical shift 
assignments for residues within the protein sequence still remain missing, however, for 
portions of TMD2 and TMD3, as well as the associated linker region and the 6XHis tag.  
Figure 3.11 shows a side-by-side view of some of the resulting data with the 600 MHz 
NMR (Fig. 3.11A) versus the 800 MHz NMR (Fig. 3.11B). 
 
Secondary structure and backbone dynamics of S105 TM1 C51A.  Collaborators Dr. 
Christian Hilty and Youngbok Lee analyzed the NMR data and obtained information 
about the secondary structure, as well as backbone mobility, for the protein sample.  
Deviations in random coil values for C  chemical shifts can be used to determine 
secondary structure, i.e. positive values are indicative of alpha-helical character, and 
negative values are unstructured (73).  In the case of S105 TM1 C51A, residues 16-35 and 
41-61, which correspond to regions of TMD2 and TMD3, had positive values (70).  In 
addition, similar deviations in random coil values for C  chemical shifts were 
determined for residues 62-71, indicating alpha helical character for this region as well.  
In contrast, negative values were determined for regions at the N- and C-termini, which 
suggest these regions are unstructured (70). Secondary structure can also be determined 
by medium-range NOEs, based on 1H-1H distances (74).  For alpha-helical structure, 
NOEs dNN and dNN(i,i+2), which correspond to distances between backbone amide 
protons on neighboring residues and distances between the alpha proton of one residue  
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Figure 3.11.  [1H][15N] TROSY-HSQC spectra of triple-labeled S105 TM1 C51A.  The 
following instruments were used: 600 MHz NMR (A) and 800 MHz NMR (B).  
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and the amide proton of a residue two positions away, respectively, can be observed in 
deuterated protein samples.  For S105 TM1 C51A, both dNN NOEs and dNN(i, i+2) NOEs, 
which are characteristic of alpha helical structures, were found in the TMDs, and at the 
region beginning with residue 62 (70). 
 Heteronuclear 15N{1H}-NOE enhancement and 15N-T1 and T2 relaxation times 
were used to determine the backbone mobility of S105 TM1 C51A.  Enhancement values 
indicate the relative flexibility of a polypeptide chain (75).  Specifically, rigid regions of 
the backbone give enhancement values of +0.8 and less rigid regions have negative 
values. According to the results, residues within the TMDs of S105 TM1 C51A, as well as 
residues 62-71, have enhancement values which indicate rigid structure.  In contrast, 
residues 69-94, which correspond to the C-terminus, have negative enhancement values, 
or less rigid structure (70).  In addition to enhancement values, T1 and T2 relaxation 
measurements can also be used to assess backbone dynamics, i.e. increased T1 and 
decreased T2 are associated with rigid structure (75).   For S105 TM1 C51A, T1 and T2 
values for both termini suggest increased flexibility or mobility.  However, the T1 and T2 
relaxation times for the TMDs were significantly different (70).   
Due to the appearance of additional NMR peaks in aging samples, there were 
indications that the protein was undergoing conformational changes (70) (Fig. 3.12).  
The changes did not appear to be consistent with degradation, but rather a slow process 
of dimerization and/or oligomerization. To determine whether the protein was changing  
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Figure 3.12. 2D-TROSY spectra of newly-prepared sample (A) and aged sample (~10 
days) (B).  Blue circles indicate new peaks (70).     
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over time, gel filtration and chemical crosslinking were used to assess the oligomeric 
state of S105 TM1 C51A.  Specifically, dithiobis (succinimidyl-propionate) (DSP) 
crosslinking was performed on the labeled NMR sample, and gel permeation 
chromatograms were compared for 3-month old aged and freshly-prepared protein 
samples.  DSP-crosslinking of the NMR sample indicated that there was some dimer 
formation in the aged sample (Fig. 3.13). The gel permeation results indicated that 
although the majority of the protein remained in a monodisperse peak which seemed to 
be consistent with a monomeric species, the secondary peaks differed depending on the 
age of the sample (Fig. 3.14).  In the newly-made sample, the secondary peak was 
positioned consistent with a dimer, whereas the aged sample had a secondary peak 
consistent with a larger-sized oligomer.   
 
Discussion  
 As a result of these collaborative studies, there has been significant progress in 
the effort to determine the solution structure of the lambda holin mutant, S105 TM1 C51A.  
Over 60% of the amino acids have been identified as spin systems; however, there are 
still a number of residues without assignments.  The data confirm the placement of at 
least one of the TMDs within the protein, as well as the placement of the highly charged 
and less structured C-terminal tail.  In addition, both micelle-embedded and water-
exposed regions have been differentiated and identified.  NMR studies have also 
provided evidence of secondary structure in the form of the alpha-helical character   
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Figure 3.13.  Western blot of DSP-crosslinked S105 TM1 C51A.  Lane 1: molecular weight 
marker; lane 2: NMR sample; lane 3: NMR sample, -DSP; Lane 4: NMR sample, + DSP  
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Figure 3.14.  Gel permeation chromatograms for S105 TM1 C51A (comparison of aged and 
newly-made samples).  Aged (3-month old sample), pink; newly-prepared sample, red. 
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for the TMDs and the possibility of an extended helix at the bottom of TMD3.  In 
addition, these studies have indicated regions involved in backbone dynamics for the 
lambda holin mutant S105 TM1 C51A (70).   
 Although significant progress has been made on this project, there are several 
experiments still to be done so that the NMR solution structure of the lambda holin 
mutant, S105 TM1 C51A, can be completed.  To begin, future work on this project will 
involve selectively-labeling amino acids within the protein, in an effort to verify current 
assignments, as well as acquiring the remaining chemical shift assignments.  The strain 
DL39(DE3) (76-77), which is auxotrophic for the following amino acids: leucine, 
isoleucine, aspartic acid, valine, phenylalanine, and tyrosine, will be used to express the 
selectively-labeled protein.  Secondly, paramagnetic relaxation reagents will be used to 
more definitively determine which parts of the protein are exposed to water or actually 
embedded in the lipid micelle.  Specifically, the reagent Gd-DTPA is a water-soluble 
spin label which only affects water-exposed regions of the protein, and lipophilic 16-
doxyl stearic acid only affects micelle-embedded regions.  Finally, and perhaps most 
importantly, the optimized conditions for sample preparation and NMR spectroscopy of 
S105 TM1 C51A will be used to study the structure of the wild-type lambda holin, S105, as 
well as other bacteriophage holin proteins.   
 
Materials and Methods 
Plasmids and strains.  The plasmid used for this work was pET11a S105 TM1 C51A, 
which has ampicillin resistance.  pET11a S105 TM1 is the same as pET11a S105 (2) with 
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the sequences encoding residues L9 through A30, which comprise TMD1 of S105, 
deleted.  pET11a S105 TM1 C51A was made by Quickchange site-directed mutagenesis of 
pET11a S105 TM1, converting the cysteine residue at position 51 to alanine.  The strain 
used for protein expression was C43(DE3) tonA::Tn10 (61). 
 
Reagents and instruments.  All labeled NMR reagents for minimal media, including 
D2O, 13C-glucose, and 15N-ammonium chloride were purchased from Spectra Stable 
Isotopes (Cambridge).  The remaining reagents used for minimal media were obtained 
from Sigma.  All NMR experiments were carried out with the following instruments: the 
Varian 500 MHz NMR with triple resonance probe (Texas A&M University), the Varian 
600 MHz NMR with triple resonance probe (Texas A&M University), the Varian 800 
MHz spectrometer with triple resonance probe (Pacific Northwest National Lab) and the 
Bruker 800 MHz NMR spectrometer with cryoprobe (The University of Houston). 
 
Media preparation.  One liter of solution Q was made according to the following recipe: 
8 ml HCl, 5 g FeCl2 4H2O, 184 mg CaCl2 2H2O, 64 mg H3BO3, 18 mg CoCl2 6H2O, 4 
mg CuCl2 2H2O, 340 mg ZnCl2, 605 mg Na2MoO4 2H2O, 25.4 mg MnCl2 in H2O at a 
final volume of 1 L.  The solution was filter-sterilized and stored at room temperature. 
One hundred milliliters of vitamin mix was made according to the following recipe: 50 
mg thiamine, 10 mg D-biotin, 10 mg choline chloride, 10 mg folic acid, 1 mg 
niacinamide, 10 mg D-pantothenic acid, 10 mg pyridoxal, and 1 mg riboflavin in H2O at 
a final volume of 100 ml.  The vitamin mix was filter-sterilized and stored at -20 °C.  
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Two liters of minimal media were made according to the following recipe: 25.6 g 
Na2HPO4 7H2O, 6 g KH2PO4, 1 g NaCl, dissolved in ~1.9 L D2O.  Two milliliters of 
solution Q, 4 ml 1M MgSO4, 20 ml vitamin mix, 4 g 13C6-D-glucose, and 2 g 15NH4Cl 
were added and stirred gently until all contents dissolved.  D2O was added to the media 
to bring the final volume to 2 L.  The media was filter-sterilized and stored at 4 ºC. 
 
Culture growth for protein purification.  Cultures were grown as previously described 
with some changes (25, 64).  C43(DE3) tonA::Tn10 cells were transformed with pET11a 
S105 TM1 and plated on LB agar containing 100 mg/ml ampicillin.  Ten-fifteen colonies 
were used to inoculate a 30 mL LB culture containing 100 mg/ml ampicillin.  This 
starter culture was grown to OD = 0.6 at 37 °C with gentle shaking, then used to 
inoculate two 1 L culture flasks of [2H][13C][15N]-labeled minimal media at a dilution of 
1:100.  The large cultures were grown to OD = 0.6 at 37 °C with gentle shaking, then 
induced for expression of S105 TM1 or S105 TM1 C51A with 1 mM IPTG. The induced 
cultures were grown for 3 additional hours, then the cells were harvested and stored at  
-20 °C.  
 
Protein purification.  Protein purification was carried out as previously described, (25, 
64) with the following exceptions.  20 mM Phosphate pH 7.8, instead of 20 mM Tris, 
was used for the following purification buffers, including lysis buffer, extraction buffer, 
buffer A, low imidazole buffer, and elution buffer.  The detergent used for purification 
was LDAO, at a final concentration of 20 mM in the extraction buffer and 4 mM in the 
 91 
purification buffers. Following Talon purification, the protein was applied to a Sephadex 
200 gel filtration column and eluted at 0.5 ml/min into 1 ml fractions of buffer 
containing 20 mM Phosphate pH 6.5, 150 mM NaCl, 4 mM LDAO.  The fractions 
containing protein were concentrated with a 3 K MWCO Amicon centrifugal 
concentrator (Millipore) to a final volume of 250 l.  The final protein concentration was 
~1 mM in buffer containing 20 mM phosphate, 150 mM NaCl, and 128 mM LDAO. 
 
NMR spectroscopy and data analysis.  All NMR spectroscopy and associated data 
analysis was carried out by Dr. Christian Hilty and Youngbok Lee.  A Bruker 800 MHz 
NMR spectrometer with cryoprobe was used for triple resonance experiments, with 
specified parameters such as carrier frequency, spectral width, time-domain data size, 
maximum evolution time, and number of scans.  The following experiments were carried 
out: 3D-TROSY-HNCA, 3D-TROSY-HNCACB, 3D-TROSY-HNCO, 3D-TROSY-
HN(CA)CO, 3D-TROSY-HN(CO)CA, 3D-15N-resolved [1H,1H]-NOESY.  A Varian 
800 MHz spectrometer with triple resonance probe was used for determination of 
backbone dynamics.  All of the data were collected at 35 °C.  Data were processed using 
the NMR pipe software (78). Some of the data acquired on the Bruker spectrometer were 
processed directly with the Topspin software. The program CARA (79) was used for 
chemical shift assignments and peak integration (70).  
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CHAPTER IV 
MICRON SCALE HOLES TERMINATE THE PHAGE INFECTION CYCLE*  
 
 Bacteriophage lysis, the most frequent cytolethal event in the biosphere, is a 
precisely scheduled process controlled by proteins of the holin family (4). Holins are an 
extremely diverse class of small, phage-encoded membrane proteins (6). The best 
studied holin is S105, a 105-residue polypeptide with three TMDs encoded by the S gene 
of phage . Throughout the period of late gene expression and particle assembly, 
S105 accumulates in the cytoplasmic membrane of E. coli without any effect on its 
integrity (38).  Suddenly, at a programmed time, S105 triggers to form a lesion, or hole, 
in the membrane; this allows the  endolysin, R, to escape from the cytoplasm and attack 
the cell wall (6).  In phages of Gram-negative hosts, there is a third step to complete the 
lysis pathway involving a protein or protein complex, the spanin, which connects the 
cytoplasmic and outer membranes (13, 80).  In , the spanin complex consists of the 
cytoplasmic membrane protein Rz and the outer membrane lipoprotein Rz1.  This 
complex is essential for lysis in media containing millimolar concentrations of divalent 
cations and thus is thought to act by disrupting the 
 
 
 
 
 
___________ 
*Reprinted with permission from Dewey JS,Savva, CG, White, RL, Vitha, S, Holzenburg, 
A, and Young, R. (2010) Micron-scale holes terminate the phage infection cycle. Proc 
Natl Acad Sci U S A 107(5) 2219-2223.   
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outer membrane, possibly by fusion with the inner membrane (13).   
Although the S105 holin has been extensively studied using genetic and 
biochemical approaches (10, 14, 16, 25, 38), nothing is known about the membrane 
holes except that they are non-specific and large enough to allow escape of fully folded, 
tetrameric  R- -galactosidase chimeras (>450 kDa), indicating that they are of 
unprecedented size for channels made by integral membrane proteins (20).  Recently, 
cryo-electron microscopy (cryo-EM) studies of detergent-purified S105 revealed large 
ring assemblies with two main size groups consisting of 18 and 20 protomers 
respectively,  with the majority class, 18mers, having an inner diameter of ~ 8.5 nm (25).  
S105 in these purified complexes retained -helical content and protease sensitivity 
consistent with the membrane topology in vivo, as determined by genetic and 
biochemical experiments (14). However, the nature of the S105 lesion in the host 
membrane has remained elusive. The lumenal diameters observed are not consistent with 
the ability to release endolysin- -galactosidase chimeras of ~0.5MDa mass.  Attempts to 
visualize the membrane lesions by conventional ultra-thin-section electron microscopy 
have been unsuccessful (81), in part because of the structural deformations associated 
with the multiple fixation, dehydration and staining steps (82). 
Rapid freezing at liquid ethane temperatures allows complete preservation of 
biological material below ~2 m in size, in a native hydrated environment (83-84). 
Furthermore, the millisecond fixation allows time-dependent biological processes to be 
captured essentially instantaneously (85). We reasoned that by examining cells  
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expressing S105 in the absence of R, Rz and Rz1, we could observe the sole effect of the 
holin on the host cell. Furthermore, by utilizing cryo-EM, we would be able to image the 
cells in a physiologically relevant state.  The results of these studies are discussed in 
terms of a model for the molecular pathway of holin-mediated lysis. 
 
Results 
Expression of S105 leads to large membrane gaps in the E. coli inner membrane. To 
examine the effect of S105 on the host, we used E. coli strains expressing the holin in the 
presence and absence of the endolysin R and the spanin complex proteins, Rz and Rz1 
(Fig. 4.1A). It was important to characterize the lysis behavior of the strains prior to their 
imaging by cryo-EM. Cultures expressing S105 with and without R, were grown and 
induced for expression of the lysis genes (Fig. 4.1B).  The strain harboring pSRRzRz1, 
with functional alleles of all the genes of the  lysis cassette, lysed as expected at 
approximately 50 min.  The strain carrying pS, expressing S105 alone, ceased growth at 
50 min, indicative of hole formation in the cytoplasmic membrane, but, because of the 
absence of endolysin activity, did not undergo lysis.  In order to visualize the effect of 
S105 alone on the host membrane, a 60 minute sample of an induced pS culture was 
plunge-frozen into liquid ethane without any further manipulation (i.e. concentrating or 
washing).  Specimens were then imaged under liquid nitrogen temperatures and low-
dose conditions, revealing rod-shaped cells with intact outer membranes. Upon closer 
examination, about half of the cells displayed an apparent discontinuity in the inner  
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Figure 4.1. Plasmids used in this study (A). Lysis curves of cultures carrying (B): no 
S105 plasmid, (◊); p0 (■); pS,(●); pSR, supplemented with 10 mM MgCl2 (□); 
pSRRzRz1 (○).The arrow shows the 60 minute timepoint at which samples were taken 
for cryo-EM. 
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Figure 4.2. Cryo-EM of the S105 lesion. Cells were grown and imaged as described.  A 
cell expressing S105 is shown in A. The area enclosed in the white-dashed box is shown 
enlarged in B. The white solid lines indicate the location and extent of the lesion. The 
dashed white line indicates an area of semi-continuous membrane density. Close-up 
views of the S105 lesions from two other cells (C, D). Scale bar corresponds to 500 nm. 
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membrane density (Figs. 4.2, 4.3A).  These gaps ranged in size from 88 nm to 1.2 m, 
with an average size of ~340 nm (Figs. 4.2B-D, 4.3B).  The lesions were not localized to 
a specific region in the inner membrane but appeared randomly throughout its periphery, 
irrespective of size (Fig. 4.3C, D).  Taking into account the geometry of viewing in the 
vitreous ice, the observed diameters, and the random positioning of the lesions, 
calculations indicated that there must be ~2 holes per cell (Fig. 4.4).  In order to confirm 
that these inner membrane gaps were associated with S105 function, cells expressing an 
isogenic null Sam plasmid (p0) were also visualized. Among 45 cells from two different 
experiments, none displayed an inner membrane discontinuity (Figs. 4.3A, 4.5B). These 
data indicate that the large gaps observed in the cells expressing S105 are in fact the 
lethal holes that allow the endolysin access to the cell wall immediately prior to cell 
lysis.  The unprecedented size of the holes, more than 10-fold larger than those formed 
by pore-forming cytolysins (21), accounts for the ability of S105 to cause release of 
unrelated, prefolded endolysins with heterologous structure (6)  and of the megadalton 
scale R- -galactosidase chimeras (20).  
 
Cryo-tomography of the S105 lesions.  To visualize the overall structure of the S105 
lesion, cryo-electron tomography was carried out on E. coli cells expressing S105.   
Initial attempts were complicated by the large size of the LB-grown cells; the electron 
path through the specimen at 60° is twice that at zero tilt. Hence, a cell of ~ 1 m width 
results in images of very poor signal due to the multiple inelastic scattering events 
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Figure 4.3. Quantification of (A) the number of S105 holes per cell, (B) hole size 
variation, (C) hole localization, and (D) relationship of hole size to location. 
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Figure 4.4. Diagram depicting the calculations for the probability of observation of a 
340 nm lesion (at a 0° tilt). The circle represents the circumference of a rod-shaped cell 
along its width (cells observed had an average width of ~1000 nm). A 340 nm lesion 
(which spans ~40° range) can be observed when part of it is located at the xy plane.  
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Figure 4.5. Cells expressing S105 (pS) (top) or Sam7 (bottom). A continuous inner 
membrane was characteristic of all cells expressing Sam7. Scale bars correspond to 500 
nm. 
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despite the use of an energy filter. In an attempt to reduce the size of the cells, we took 
advantage of the coupling between cell mass and growth rate (86) and tested several 
minimal medium conditions (87) for the ability to support the slowest possible growth 
rate but still allow the precisely-scheduled lysis characteristic of cells grown in rich 
medium.  Among several carbon-sources tested, succinate was found to support a 
doubling time of 80 min and preserved rod-shaped morphology; induction of the fully 
functional lysis cassette led to a sharply-defined lysis at 30 min after induction (Fig. 4.6).  
Phase-contrast microscopy as well as cryo-EM examination revealed that the average 
cell length and diameter were reduced by >30%, leading to a final relative volume of 
~20% of that observed in LB (Fig. 4.7).  We examined induced cells for lesions smaller 
than ~200 nm in order to acquire tomographic data completely spanning a hole.  Two 3D 
reconstructions of cells induced in succinate minimal medium were obtained (Fig. 4.8; 
Fig. 4.9).  Slices through the tomogram shown in Fig. 4.8 show the appearance of a 
lesion with a maximum diameter of ~130 nm across the xy plane and its subsequent 
disappearance over a z range of ~125 nm. The actual height of the lesion is less when 
taking into account elongation effects along z due to the missing wedge (88-89). 
Segmentation of the cell envelope densities in both tomograms (Fig. 4.8B; Fig. 4.9C) 
revealed that the lesion in each case was irregular in shape.  Although irregular, the 
lesions resemble a roughly circular shape; i.e. they are not elongated along a particular 
axis. 
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Figure 4.6. Growth curves of cultures carrying no S105 plasmid (●), pS (■), or 
pSRRzRz1(▲), grown in succinate-minimal media and induced with IPTG at t=0. 
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Figure 4.7. Light micrographs of cells grown in LB (A) and succinate media (B). The 
average length of cells grown in LB and succinate is 3.8 m and 2.9 m respectively, 
while the average width measures 0.97 m in LB and 0.77 m in succinate (as measured 
by cryo-EM). Measurements using light microscopy closely matched the above results. 
Scale bars correspond to 2 m. 
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Figure 4.8. Cryo-electron tomography of an S105 lesion. The cell shown (A, inset) 
expressing S105, was tilted +/- 55º and a three-dimensional reconstruction was 
calculated. A close-up of the lesion in projection is highlighted by the white arrow. 
Segmentation of the envelope densities (B) shows the outer membrane (blue) and inner 
membrane (orange). 2.6 nm-thick slices along z (C-H, spaced by 26 nm) show the 
appearance of a lesion and its subsequent disappearance over a z-height of ~125 nm. 
Arrows indicate the S105 lesion. Scale bar corresponds to 250 nm. 
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Figure 4.9. Cryo-electron tomography of a cell expressing S105. A zero tilt projection 
image (A) and a ~25 nm thick slice through the tomogram (B). The observed lesion is 
highlighted by arrows and displayed in 3D (C) after segmentation of the inner (dark 
blue) and outer membrane (light blue) densities. Scale bar corresponds to 500 nm.  
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The holin-endolysin system effects dramatic changes on E. coli, immediately prior to 
lysis.  Having observed the effect of S105 alone on the cell envelope, we sought to 
visualize cells under conditions that permit complete host cell lysis, i.e., with co-
expression of the endolysin R (Fig. 4.1). In images of samples taken at 60 min, the great 
majority of these cells had undergone complete lysis, as evident from the presence of 
cellular debris.  However, we were able to capture rare instances of cells that had not yet 
lysed. These cells had lost the characteristic rod shape of E. coli and were completely 
spherical (Fig. 4.10).  Because neither Rz or Rz1 is functional, the outer membranes of 
these cells were still intact.  Nevertheless, the inner membrane sacs were collapsed, with 
evident release of cytoplasmic contents.  As shown in Fig. 4.11, in the absence of Rz or 
Rz1 function, lysing cells can be stabilized in this spherical morphology if millimolar 
concentrations of divalent cations are supplied in the medium (90-91). Samples taken 
from an induced pSR culture in medium supplemented with 10 mM MgCl2 were imaged 
and found to contain a significantly larger number of intact, yet spherical cells similar to 
the rare unlysed cells in the absence of metal ions. This allowed us to capture various 
levels of inner membrane disruption, ranging from large membrane gaps to a total 
collapse of the inner membrane sac (Fig. 4.11). In addition, as a result of the destruction 
of the murein, most cells exhibited a significant separation of the inner and outer 
membranes.  No instances of punctate zones of adhesion, or Bayer's patches (92-93), 
between the membranes were observed, supporting the notion that either they require the 
presence of the murein or that they may be artifacts of sample preparation (82, 94). 
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Figure 4.10. Cell expressing S105 and R, without divalent cations present. For these  
conditions, most cells had undergone complete lysis as evident from the observed cell 
debris. Arrows trace the discernible inner membrane at the point of separation from the 
cell envelope. Scale bar corresponds to 500 nm. 
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Figure 4.11.  Cryo-EM of cells co-expressing the holin (S105) and endolysin (R) in the 
presence of Mg2+ ions. Cells were captured at different stages of inner membrane 
disruption including gap formation (A, B) and a more pronounced collapse of the inner 
membrane (C, D). White arrows indicate the border of membrane discontinuity (A, B) or 
the trace of the collapsed membrane (C, D). Scale bar corresponds to 500 nm. 
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Stages of early cytoplasmic leakage through the S105 hole were also observed. An 
example is shown in Fig. 4.12, where a cloud of density proximal to the inner membrane 
suggested cytoplasmic leakage through a hole. Tilting of the microscope stage confirmed 
that the leakage originated from a lesion of ~100 nm diameter (Fig. 4.12B-D) 
  
Discussion 
 For the first time, the lethal holes caused by the holin-endolysin lysis system of 
bacteriophages have been directly observed in cells.  Unexpectedly, the size of the 
membrane holes caused by the S105 protein in terminating the  infection cycle exceeds 
by more than an order of magnitude that reported for any other membrane lesion in 
biology, the largest of which are the ~30 nm pores formed by the cholesterol-dependent 
cytolysins (21, 95). Tomographic analysis confirmed that membrane gaps observed in 
projection represented actual holes, rather than invaginations or deformations.  In 
addition, it could be established that the holes were irregular in shape, unlike the highly 
symmetric cytolysin pores which make the next largest membrane holes observed to date 
(95).  These results contradict the previous ultrastructural study, which failed to detect 
any interruptions in the integrity of the cytoplasmic membrane after function of the S 
holin (81); however, the previous work used thin-sections of cells subjected to harsh 
fixation and dehydration steps. 
The existence of holes of such unprecedented size is even more remarkable, 
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Figure 4.12. Early stages of cytoplasmic leakage from a cell co-expressing S105 and R. 
The 0º image indicates a cloud of density escaping from the cytoplasm (A, B). Tilting of 
the stage by 20º (C) and 30º (D) revealed the membrane lesion from which the leakage 
originated. Scale bar corresponds to 500 nm. 
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considering that throughout the infection cycle until the moment of triggering a few 
seconds before lysis, the accumulation of S105 in the host membrane has no effect on 
the integrity of the membrane or its energy-generating capacity (38).  This reflects the 
extreme, but opposed, selection pressures on holin function as the timer for the latent 
period; i.e, the holin should not compromise the capacity of the host for macromolecular 
synthesis until the programmed instant of triggering. However, after triggering, it should 
effect a rapid, efficient release of the cytoplasmic endolysin and thus minimize the delay 
between triggering, which terminates macromolecular synthesis, and the liberation of the 
progeny virions. It is even more remarkable that the timing of this all or nothing event 
can be adjusted drastically with a single missense change throughout the sequence of the 
 holin (11, 16), and, indeed, of other unrelated holins (35, 96), of which there is 
staggering diversity of sequence and topology (6). 
Although the molecular basis of holin triggering is still unknown, the results 
presented here provide a clear basis for the oldest observation about holin physiology, 
that bacterial respiration and macromolecular synthesis cease when S triggers (81, 97-
98).  A single hole of this size would be incompatible with the maintenance of either 
process.  Importantly, although the formation of these holes and its temporal scheduling 
are unambiguously and solely dependent on holin function (6), the role of the S105 
protein in the structure of the large lesions is not established.   The 8 - 9 nm ring 
structures formed by purified S105 in detergent (25) are orders of magnitude too small to 
represent the membrane lesions described here.  Although we as yet have no direct 
evidence addressing whether S105 participates directly in the holes, alternatives are 
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more difficult conceptually.  One extreme alternative is that the triggering of S105 
causes a small channel to form, perhaps on the scale of the detergent rings, resulting in 
collapse of the membrane energization, a local disruption in the organization of the lipid, 
and then propagation of that distortion due to loss of tensile strength of the bilayer, 
perhaps forcing the imposition of hexagonal phase at the edges of the hole.  In support of 
this notion, transmembrane domains have been shown to stabilize non-bilayer lipid 
structures (99); however, such transitions require a relatively high protein to lipid ratio, 
whereas holins trigger at low protein concentrations (on the order of 103 per cell for 
S105) (6).   Alternatively, the triggering of S105 could suddenly template the 
oligomerization and conformational change of unidentified host proteins.  This notion is 
problematic, in view of the fact that S105 is also lethal when induced in yeast (100) and 
mammalian cells (101).  In addition, even at these enormous sizes, the perimeters of the 
holes are consistent with the numbers of S105 holins present at the time of lysis.  Since 
each holin has three TMDs, which as alpha-helices are ~1 nm in diameter, current 
estimates of ~1000 S105 molecules (18, 62) could correspond to ~3 m of perimeter, if 
all the proteins are in the perimeter and each TMD participates.   To settle this issue, the 
ideal approach would be to tag S105 with a fluorescent moiety and use correlative 
microscopy to demonstrate the presence of the holin in the lesion.  However, to date, this 
technology has not been successfully applied to E. coli.   
Assuming the simplest idea, that, like all other cytolytic membrane proteins, 
S105 actually forms the walls of the hole, it is conceivable that smaller S105 rings do 
form first in the membrane and then coalesce into the macroscopic lesions observed 
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here. Suggestive evidence for this can be seen in the perforated appearance of certain 
lesions (Fig. 2B). Genetic, physiological and biochemical data have led to a model in 
which the S105 holin forms large two-dimensional aggregates, or "death rafts", during 
the lysis pathway (20).  The large holes described here can be viewed as supporting the 
notion that at the time of lethal triggering, the S105 holin exists in such large aggregates, 
leading to one or a small number of holes, rather than many smaller holes distributed 
throughout the membrane.  Current work is aimed at generalizing the observation to 
other, unrelated holins and developing in vitro hole-formation methodology using 
purifed S105 holin and liposomes.  Hopefully these approaches will provide further 
insight into the mysterious mechanism by which the holin manages the temporally-
scheduled transition between the perfectly maintained membrane integrity of the pre-
hole state and the massive membrane holes described here.   
 
Materials and Methods 
Plasmids and strains.  The plasmid pSRRzRz1 is identical to pS105 (2) and carries the 
 lysis gene cassette, S105RRzRz1, under the control of the native  late promoter, pR'; 
S105 is an S allele which produces S105, the holin, but not S107, the antiholin, by virtue 
of the conversion of codon 1 from ATG to CTG. The plasmid pSR is isogenic to 
pSRRzRz1 but carries the nonsense alleles RzQ100amRz1W38am. The plasmid pS is 
isogenic to pSR, except that it carries a silent mutation (C to T at λ nt 44594, which 
ablates an AatII site) and two nonsense mutations, Q26am and W73am, (previously 
identified as Rsus54sus60) (102), in R. p0 is isogenic to pS except that the S105 allele is 
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replaced by the nonsense allele Sam7 (39). The plasmid pQ is a single-copy vector with 
 gene Q cloned under the control of Para-lac (38); pQc is isogenic to pQ except that 
the kanR marker was replaced by camR, for use in kanR hosts.  The hosts used were 
derivatives of the sequenced E. coli K-12 strain, MG1655 (103). A lacY derivative was 
constructed by replacing the lacY gene in MG1655 fhuA lacIq with ΔlacY::kan, in 
which a kan cassette flanked by Flp recombinase sites is substituted for the entire lacY 
reading frame (104). MG1655 fhuA lacIq lacY::kan was transformed with pQc, 
creating RY16505. RY16504 is isogenic to RY16505 except it carries pQ instead of pQc 
and the kan cassette was excised from lacY::kan by Flp recombinase (104). 
 
Growth conditions and monitoring. For all experiments except those shown in Figs. 
4.10-4.12, the bacterial host used was RY16504.  For Figs.4.10-412, the host was 
RY16505. Cultures were supplemented with 100 g/ml ampicillin and either 40 g/ml 
kanamycin (RY16504) or 10 g/ml chloramphenicol (RY16505). In addition, pSR 
cultures were supplemented with 10 mM MgCl2, which stabilizes the outer membrane in 
the absence of RzRz1 function. For cultures grown in LB, 100 l of overnight cultures 
grown in LB supplemented with the appropriate antibiotics, harboring the indicated 
plasmids, were used to inoculate 25 ml of LB. The identical procedure was used for 
succinate minimal media, except 10 l of overnight cultures were used for inoculation.  
All cultures were induced with 1 mM IPTG at A550 = 0.2 (for lysis curves) or A550 = 0.4 
(for cryo-EM).  
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Cryo-electron microscopy and cryo-tomography. For cryo-EM, cells were withdrawn at 
60 min after induction, mixed with BSA-coated gold tracer (10 or 25 nm) and 
immediately applied to C-FLAT (CF-4/2-2C) or home-made lacey carbon-coated grids 
that had been glow-discharged just prior to use. Grids were then plunge-frozen in ethane 
using an FEI Vitrobot. Specimens were loaded into a GATAN 626 cryo-holder and 
observed with an FEI Tecnai G2 F20 TEM equipped with a GATAN Tridiem imaging 
filter using zero-loss imaging and low-dose conditions with typical doses of 3-5 e-/Å2 per 
image. For cryo-electron tomography, specimens were prepared as above but cells were 
gently concentrated 20-fold by vacuum filtration through a 0.22 m filter. Tilt-series 
were acquired automatically using the FEI Xplore3D software and the Saxton tilt 
scheme (105). The tilt range varied from +/- 53° to +/- 60° and the total electron dose for 
each series was kept below 100 e-/Å2. Tilt-series alignments, 3D reconstructions and 
tomogram segmentations were carried out using the IMOD (106) tomography package. 
Tomograms were filtered using nonlinear anisotropic diffusion (107) as implemented in 
the IMOD package.  
 
Geometry of the lesions and probability of observation.  A lesion in the inner membrane 
can be observed in the transmission electron microscope if part of the lesion is located at 
the edge of the cell and perpendicular to the optical axis in a given cell orientation. 
Assuming a circular hole with a diameter of 340 nm, the probability of its visualization 
can be approximately calculated from the angle formed by the edges of the hole and the 
center of mass of the cell (Fig. 4.4). This calculation results in a 40° angle for an average 
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cell width of 1000 nm. Thus the probability of observing such a hole is ~ 22%. 
(40°/180°, where 180° is the image projection range on one side of the cell).  Since holes 
are observed in 48% of the cells, these data suggest that ~2 holes are created on average 
in a cell induced for S105 expression; see Fig. 4.3A.  
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CHAPTER V 
CHARACTERIZATION OF BACTERIOPHAGE HOLINS 
AND THEIR LESIONS 
 
Part I: Characterization of the P2 Y Holin 
 The lysis cassette of bacteriophage P2 contains the following genes: Y, K, lysA, 
lysB, and lysC (26, 108).  The P2 lysis genes were initially identified and analyzed based 
on sequence similarities to other phage lysis genes.  In addition, conditional and 
nonsense mutants of each gene were isolated and analyzed in terms of their lysis 
behavior, and the mutant phenotypes were used to ascribe functions to the proteins they 
encode.  It was determined that genes Y and K were necessary and essential for P2 lysis, 
whereas genes lysA and lysB were nonessential (26).   
Y, which is the subject of this chapter, is the P2 holin gene, and it encodes a 93 
amino acid protein.  The Y protein is responsible for permeabilization of the E. coli 
cytoplasmic membrane by forming lesions which are believed to be similar to those of 
the lambda holin, during late gene expression.  Although P2 Y and lambda S do not 
share any sequence similarity, the predicted overall topologies of the two proteins, as 
well as the amino acid charge distributions, are the same. Both have three regions of 
hydrophobic residues which are believed to comprise TMDs as well as charged termini 
and loop regions (Fig. 5.1).  K is the P2 endolysin which degrades the cell wall layer 
after crossing the inner membrane barrier through the Y-lesion.  The sequence of P2 K  
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Figure 5.1.  Comparison of predicted topology for P2 Y (left) and known topology for 
lambda S105 (right).  The charged side chains of amino acids are indicated by plus signs 
(positively-charged residues) and minus signs (negatively-charged residues).  
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shares 57% identity (69% similarity) with lambda R (26).  lys A, which encodes a 141 
amino acid protein, has been shown to delay lysis when expressed with the holin, 
and so it is considered the P2 antiholin (26).  Unlike lambda, the P2 holin and antiholin 
are encoded by two separate genes, instead of a single gene with a dual-start motif.  
Finally, lysB and lysC encode Rz and Rz1-like spanin proteins (13), respectively, and are 
thought to play a role in outer membrane destabilization during host cell lysis (108).   
 
Results 
Genetics of Y lysis timing. Several missense mutations were made within the 93 amino 
acid sequence of P2 Y to determine whether single amino acid changes would affect the 
timing of lysis, as is characteristic of the lambda holin and other holins (see Chapter I).  
Site-directed mutagenesis, or Quickchange, was used to convert the following residues: 
S46C, A49T, G50A, G50C, G50V, G50S, and C65G.  These missense mutants were 
then tested for lysis behavior by monitoring their growth in liquid cultures (Fig. 5.2).  
The results showed that the mutant A49T, as well as all of the G50 mutants thus far 
tested, were non-functional, indicating that these residues within TMD2 were important 
in helical interactions.  In contrast, mutants S46C and C65G were lytic and the timing of 
lysis was similar to that of wild-type Y.   SDS-PAGE and Western blotting with an 
antibody directed at the C–terminus of Y were used to determine whether the single 
missense changes affected protein expression.  The results showed that all of the 
missense mutants expressed Y protein (Fig. 5.3). 
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Figure 5.2.  Lysis behavior of P2 Y mutants.  Strain MC4100 tonA ( Cam SR) was 
used for all curves, and Y mutants are expressed in trans from plasmid pY(mut)RRzRz1; 
pYwtRRzRz1 (orange), pYS46ARRzRz1 (yellow), pYC65GRRzRz1 (red), pYamRRzRz1 
(green), pYG50CRRzRz1 (light blue), pYG50VRRzRz1 (dark blue), pYG50SRRzRz1 
(purple), pYG50ARRzRz1 (gray), pYA49TRRzRz1 (black).  
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Figure 5.3.  Western blot of Y mutant protein expression.  Protein was expressed from a 
plasmid, along with the lambda lysis genes R, Rz, and Rz1, and transformed into the 
strain MC4100 tonA ( Cam SR).  Whole cell samples were collected for TCA 
precipitation 1-2 min prior to lysis or at 60 min for the non-lysing mutants. Lane 1: 
molecular weight marker; lane 2: Ywt; lane 3: YC65G; lane 4: YS46A; lane 5: YG50S; lane 6: 
YG50A; lane 7: YG50V; lane 8: YG50C; lane 9: YA49T; lane 10: Y TM1; lane 11: Yam.  
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A truncation mutant of the lambda holin, S105 TM1, in which the entire first 
TMD has been deleted, was shown to function as an antiholin when expressed in trans to 
S105 (65).  To determine whether this was a unique characteristic of the lambda holin, or 
an observation common with other class I holins, we sought to create the corresponding 
mutant for P2 Y, Y TM1.  This new mutant, which lacks the residues comprising the 
putative first TMD of P2Y, Ser7-Lys22, was expressed on a plasmid in trans to full-
length Y that was expressed from a prophage (Fig. 5.4).  The results show that Y TM1 
delays lysis by full-length Y when the two proteins are co-expressed in liquid culture.  
Again, SDS-PAGE followed by Western blotting with an antibody specific to the Y C-
terminus were used to show that the truncation mutant Y TM1 does in fact express protein 
(Fig. 5.3).      
 A third type of mutation was created via site-directed mutagenesis in which the 
C-terminal tail of P2 Y was truncated.  Like S105, Y appears to have a highly charged 
C-terminal tail (Fig. 5.1).  For cells expressing the lambda holin, it has been shown that 
the basic C-terminus of the S protein is not necessary for host cell lysis (17, 71-72).  In 
fact, it was shown to play only a regulatory role in lysis timing, and was characterized as 
a cytoplasmic regulatory domain.  As long as one positive charge remained at the C-
terminus, lysis occurred; however, changing the number of basic residues varied lysis 
timing considerably by making lysis faster or slower than full-length, or wild-type, S 
(71).  We sought to determine whether the C-terminal tail of Y is required for lysis and 
whether it too regulates lysis timing for phage P2. Residues R86-Q93 were deleted 
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Figure 5.4.  Y TM1 delays Y-mediated lysis.  Y TM1 was expressed in trans to full-length 
Y.  Two lysogenic strains were used for expression of Y; MC4100 tonA ( Cam SR) 
was used for expression of Y and the lambda lysis genes R, Rz, and Rz1 from a plasmid, 
and MC4100 ( -Y) was used for expression of Y and the lambda lysis genes R, Rz, and 
Rz1 from the integrated prophage.  Y TM1 was expressed from a plasmid.  The lysis 
curves correspond to the following strains:  MC4100 ( Cam SR) (black), MC4100 
( Cam SR) + pY TM1 (purple),  MC4100 ( Cam SR) + pYRRzRz1 (green), MC4100 
( -Y) (red), and MC4100 ( -Y) + pY TM1 (blue).  
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leaving only a single basic residue at the C-terminus of the protein, and the mutant was 
named Y C-term.  The results suggest that residues 86-93 are in fact necessary for host cell 
lysis and/or proper protein expression because induction of the mutant, Y C-term, resulted 
in a non-functional protein (Fig. 5.5).  The results do not rule out the possibility that 
deletion of the C-terminus negatively affects expression of the Y protein.  Since the 
available Y antibody recognizes the C-terminus of the protein, we were not able to 
determine whether Y is actually being made properly when the C-terminus is deleted.  
To determine the integrity of the protein in its truncated form, a tag should be fused to 
the protein so that an antibody that specifically recognizes the fusion tag can be used to 
verify protein expression with a Western blot. 
 
Purification of the Y protein. Biochemical characterization of the P2 holin protein 
required that we successfully over-express and purify it.  Because Y shares so many 
characteristics with S105, another class I holin for which a purification scheme has 
already been determined (2), the same strategy was applied to the P2 holin protein.   The 
construct pET30b Y was made and transformed into competent cells for over-
expression.  Once induced for 45-50 min, the cells were harvested and lysed via passage 
through a French pressure cell.  The membranes were pelleted, and the membrane 
proteins were extracted with detergent, then purified over a Talon resin column. 
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Figure 5.5.  Deletion of C-terminal Y residues resulted in a non-functional mutant.  The 
following strains were used: MC4100 tonA ( Cam SR) (black), MC4100 tonA 
( Cam SR) + pYRRzRz1 (blue), MC4100 tonA ( Cam SR) + pY C-term RRzRz1 (red).  
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 Although the overall approach described above was the same as was used for 
purification of S105, some optimization was required.  Specifically, the choice of 
detergent and conditions for membrane extraction required some trouble-shooting in 
order to obtain the most protein possible.  The following detergents were used in the 
extraction and purification of P2 Y: DDM, EBB, octylglucoside, and LDAO.  Also, the 
length of time and temperature at which membranes were extracted was optimized.  It 
was determined that extraction with DDM for 2 hours at 37 °C was the appropriate 
condition for purification of Y protein (Fig. 5.6).   
 Directly following Talon purification, the protein was further analyzed via gel 
permeation chromatography, and the major protein peak was collected for negative-stain 
electron microscopy (EM).  As shown in Fig. 5.7, the purified protein formed regular 
structures which were ~18 nm wide.  However, the majority of the protein in the sample 
did not form the spiral-shaped structures.  In an effort to obtain a homogeneous sample, 
Y was extracted from the membrane in the presence of 2,2‟ dithiodipyridine, or DTDP, 
to protect the cysteine sulfhydryl at position 65 from modification (64), and purified as 
described above.  As a result of the thiol protection, the majority of the protein formed 
regular structures in the electron microscope viewing field (Fig. 5.8).  To determine 
whether these structures were relevant and not just artifacts of the purification, we also 
purified a His6-tagged product of YA49T, a non-functional allele of Y.  The negative-stain 
EM images of purified YA49T contained structures, but the structures were irregular and 
much longer than those in the wild-type images (Fig. 5.9).  Also, the structures appeared 
to be interconnected, as if they were aggregated together.  
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Figure 5.6.  Purification results for P2 Y.  Purified Y protein remained in the membrane 
pellet from ultracentrifugation spin at 100,000 x g for 1.5 h at 4 °C, directly following 
detergent extraction step. Western blot of samples from Y purification: total membranes 
(lane 1), extracted protein (lane 2), extraction spin pellet (lane 3), and eluted protein 
from Talon purification (lane 4).   The antibody used was commercial -His6 from 
Amersham.         
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Figure 5.7.  Negative-stain EM images of gel filtration fraction containing purified Y 
protein.   The scale bar corresponds to 100 nm. 
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Figure 5.8.  Negative-stain EM image of purified Y protein extracted from the 
membrane in the presence of thiol-protecting agent, DTDP.  The sample appeared to be 
homogeneous because the majority of the protein participated in the formation of regular 
structures.  
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Figure 5.9.  Negative-stain EM image of purified Y non-lytic mutant, YA49T.  The 
mutant forms irregular, longer, and branched structures, as compared to the wt protein. 
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Discussion 
 P2 Y shares many characteristics with the lambda holin.  S105 has been studied 
extensively by genetic means, and as a result, there are many S105 mutants which vary 
in terms of lysis timing, dominance/recessiveness, and oligomerization patterns by cross-
linking (7, 14-16).  In addition, S105 has been characterized biochemically.  Detergent-
purified lambda holin protein has been shown to make regular structures, or rings, which 
can stack to form higher order structures (25).   
 In this work, we sought to characterize Y genetically and biochemically, pointing 
out along the way its similarities to S105.  First, Y was shown to exhibit sharp lysis at 
the time of triggering for hole formation.  In addition, Y was subjected to site-directed 
mutagenesis, during which single missense mutants were made, as well as an N-terminal 
truncation mutant and a C-terminal truncation mutant. The N-terminal truncation mutant, 
in which the putative first TMD was deleted, caused a delay in lysis by full-length P2 Y.  
This result suggests that Y TM1 exhibits antiholin character, much like the N-terminal 
truncation mutant of S105, S105 TM1(65).  In contrast, the C-terminal truncation mutant 
of Y did not behave like its counterpart for S105.  Y C-term, which has a single positive 
charge at its C-terminus, did not cause lysis; whereas, the S105 mutant which had a 
single positive charge at its C-terminus, did cause lysis (71).  For S105, these 
experiments, together with other results, showed that the C-terminal domain of the 
lambda holin has a regulatory function and is not required for host cell lysis (17, 71-72). 
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Y was purified according to the protocol for S105 purification, with a few minor 
changes.  The purified holin of phage P2 forms higher-order helical structures, as 
visualized by negative-stain EM.  These structures may be analogous to the stacks of 
rings formed by detergent-purified S105 (25), however, we were not able to isolate ring-
like subunits as were seen with S105. 
 
Materials and Methods 
Plasmids and strains.  The plasmids used in this work were pYRRzRz1 and associated 
mutants which were made by site-directed mutagenesis, or Quickchange.  All of these 
plasmids are derivatives of pS105 (2), and have ampicillin resistance.  The strain used 
for expression was MC4100 tonA ( Cam SR) (2). 
 
Growth conditions and TCA precipitation.  For lysis curves and protein expression 
experiments, overnight cultures were used to inoculate ~25 ml cultures of LB 
supplemented with the appropriate antibiotic.  The cells were grown at 30 °C to OD ~0.2 
(for lysis curves) and OD ~0.4 (for protein expression experiments) for thermal 
induction at 42 °C for 15 min.  Then, the cultures were shifted to 37 °C for the remaining 
time.  For protein expression experiments, 1 ml samples were removed from the growing 
cultures and added to 100% TCA on ice.  The samples were incubated for 30 min, then 
centrifuged at maximum speed in a tabletop microfuge at 4 °C.  The supernatant was 
removed and the pellet was resuspended in 1 ml cold acetone, vortexed, and spun at 
maximum speed in the tabletop microfuge at 4 °C.  The acetone wash was repeated and 
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the supernatant was removed carefully after the final spin.  The pellet was air-dried 
overnight and resuspended in 2X reducing sample loading buffer for SDS-PAGE.  
Western blotting was done with an antibody directed against the C-terminus of Y 
(Genscript).    
 
Protein purification.  P2 Y was purified according to the protocol used for over-
expression and purification of S105 (1, 25, 64), with the following exceptions.  Tris was 
used for all buffers, and DDM detergent was used in the membrane extraction and 
subsequent purification buffers at final concentrations of 1% (w/v) and 0.1% (w/v), 
respectively.  Membrane extraction was carried out at 37 °C for 2 hours with gentle 
shaking.  Protein detection was carried out with SDS-PAGE followed by Western 
blotting using the commercially available His6 antibody (Amersham). 
 
Electron microscopy.  EM grids were glow-discharged prior to use.  Five microliters of 
0.05 - 0.1 mg/ml purified protein was applied to the grid.  After ~1 min, the excess liquid 
was removed carefully with filter paper.  The grid was placed face-down on a drop of 
2% (w/v) uranyl acetate, then carefully blotted dry.  Specimens were observed in a JEOL 
1200 EX TEM (MIC, Texas A&M University).  Micrographs were recorded at 
calibrated magnifications.  
 134 
Part II: Holin Lesions 
The determinative step in the pathway to bacteriophage lysis is the formation of a 
holin-mediated lesion within the cytoplasmic membrane of the host cell.  Recently, cryo-
EM was used to visualize the lambda S105 hole in the inner membrane of E.coli, thus 
providing the first direct evidence of the holin lesion (3).  The holes were characterized 
in terms of their size and localization throughout the membrane, and cryo-electron 
tomography was used to create three-dimensional reconstructions, or tomograms, of the 
S105 hole.  The lesions were found to be much larger than anticipated with an average 
diameter of ~340 nm, and they were localized throughout the periphery of the cell (3).  
Although many aspects of the lambda holin were realized as a result of this data, many 
questions about holin lesions remained.  First, we sought to determine whether the S105 
holes were stable at their original size.  Second, we raised the question as to whether the 
large lesions are specific to the class I holin S105.  Third, we endeavored to correlate 
hole size with lysis timing. 
There are three classes of holin proteins: class I, class II, and class III.  The 
classes differ according to size, number of TMDs, and topology.  Since lambda S105 is a 
class I holin and the large lesions were visualized in cells expressing lambda S105, we 
wondered if the massive membrane holes were common among other class I holins. To 
test this, we used cryo-EM to visualize cells expressing another class I holin, P2 Y.  In 
addition, we also imaged cells expressing class II holin S68 from phage 21 and class III 
holin T from the well-studied phage T4.         
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The large collection of S105 mutants available provided a means to address the 
final question concerning these holin lesions, that is the relationship between hole size 
and lysis timing.  Over the years, S105 alleles have arisen from a variety of methods, 
including genetic selection following chemical mutagenesis, cysteine-scanning 
mutagenesis, and site-directed mutagenesis (14-16).  These mutants have been used to 
determine the topology of S105, verify the positions of the three TMDs, and determine 
oligomerization patterns for testing the hole formation pathway.  Here we have used site-
directed mutagenesis to convert two residues within the second TMD of S105 to all 
possible amino acids.  Cys51 contains the only cysteine residue within the protein.  The 
residue was mutated for cysteine scanning mutagenesis to determine the topology of 
S105, and was shown to be non-essential for S105 function (16).  Its neighboring 
residue, Ala52, was mutated to glycine and valine many years ago.  Although these two 
substituted residues are somewhat conservative changes in terms of side chain size and 
chemical composition, the mutants have opposing lysis profiles.  S105A52G lyses very 
early, while S105A52V is completely non-functional in lysis.  Cryo-EM was used to 
image cells expressing an early lysing S105 allele as well as a nonlytic mutant, and the 
data were assembled to form the current model for S105 hole formation.       
 
Results 
Determining the stability of S105 hole size.  The lambda holin S105 was shown to form 
extremely  large lesions, or holes, in the inner membranes of its host cell (see Chapter 
IV) (3).  The holes were an average diameter of ~340 nm, which is much larger than any 
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known membrane channel in biology (3, 21-22).  This raised the question of whether the 
holes are initially formed at this massive size.   A timecourse experiment was used to 
determine whether the lambda holin lesions grow in size following triggering for hole 
formation.  Samples were taken from a growing culture induced for expression of S105 
at various times following the time of triggering.  The hypothesis was that if the holes 
were not stable at the original size and they became larger over time, then the early 
timepoint samples would exhibit small hole formation and the later timepoint samples 
would show larger lesion formation. The results, however, clearly showed that the major 
size class of holes was the same, regardless of the time the samples were removed from 
the culture post triggering (Fig. 5.10).  Over 50 cells were imaged for each timepoint, 
and in all cases, the major hole size class was 200 - 400 nm.  Therefore, the holes did not 
grow and appear to be stable at their original size.   
 
Visualizing cells expressing the class I holin, lambda S105.  All of the cryo-EM 
experiments described thus far were done with an E. coli strain transformed with two 
separate plasmids: pS105 Ram Rzam Rz1am, which produces functional holin but non-
functional endolysin and spanin proteins, and pQ (3).  In order to visualize cells  
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Figure 5.10.  Cryo-EM timecourse to determine if S105 lesions increase in size over 
time.  Cells were frozen on grids at 10 min (black), 15 min (orange), 20 min (blue), 30 
min (green), and 60 min (purple) post triggering and imaged. 
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expressing other phage holins, we used a different strain background, an E.coli strain 
containing the lambda lysogen, Cam SR, which was transformed with plasmids 
containing the functional holin gene and Ram, Rzam, and Rz1am downstream of the lambda 
late promoter PR′.  The major difference between the two strains involves the source of 
Q, which is the antiterminator gene.  Q allows for expression of the lambda late genes by 
repressing the terminator tR′ located just downstream of the late promoter PR′.  For the 
strains containing pQ, the antiterminator is supplied by a plasmid, and it is induced by 
the addition of IPTG.  In contrast, the lysogenic strain containing Cam SR supplies Q 
from the prophage and the gene is expressed upon thermal induction. 
 Lambda holin lesions were visualized again, this time in the Cam SR lysogenic 
strain, expressing S105 in the absence of other lysis genes.  Fifty-two cells were imaged 
with cryo-EM, and 31, or ~60%, had visible lesions.  The holes ranged in size from 86 - 
989 nm, with the major size class being 200 - 400 nm (Fig. 5.11A).  The majority of 
cells with holes had single visible lesions, but there were instances of multiple visible 
holes per cell (Fig. 5.11B).  As in the S105 holes visualized in the other strain 
background, the visiblility of the cell membrane was limited by the position and 
orientation of the specimen on the EM grid, and geometry together with the viewing 
angle can be used to calculate the actual number of holes per cell (see Chapter IV) (3).  
The holes were localized throughout the membrane, and there was no correlation 
between hole size and hole localization (Fig. 5.11C).  In conclusion, the data from both 
expression systems used for visualizing S105 lesions agreed that holes are present within 
the inner membrane following lambda holin expression and that these holes are  
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Figure 5.11. Statistics for cryo-EM visualized holin lesions in MC4100 tonA 
( Cam SR) pS105 cells.  (A) Hole size, (B) Number of holes per cell, (C) Hole 
localization versus hole size. 
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extremely massive compared to other known membrane channels.   
 
S105 Cys51 and Ala52 missense mutants.  Site-directed mutagenesis was used to create 
single missense mutations at positions 51 and 52 within TMD2 of S105.  Specifically, 
Cys51 and Ala52 were mutated to all possible amino acids, and the alleles were analyzed 
in terms of lysis behavior, protein accumulation, and hole size.  The main question for 
the lysis timing analysis of these missense mutants was to determine whether side chain 
size correlated with lysis timing.  Some of the original S105 mutants suggested such a 
correlation.  For example, A52V has a larger side chain compared to wt (A52), which 
has a larger side chain than A52G.  According to the lysis profiles of these proteins, 
increasing side chain size resulted in prolonged or no lysis, since A52V is non-lytic and 
wt lyses later than A52G.  In the case of the C51 mutants, wt (C51) has a larger side 
chain than C51S, and again the large side chain of wt appears to inhibit or delay lysis 
timing compared to C51S, since it lyses much later.  Figure 5.12 shows the lysis profiles 
for all of the missense mutants created, and there does not appear to be a correlation 
between the substituted amino acid and the resulting lysis time as suggested by the lysis 
profiles of some original S105 mutants.  Preliminary versions of these lysis curves also 
appear in Dr. Rebecca White‟s dissertation, but have been repeated and shown here for 
the purposes of relating protein accumulation and hole size to lysis timing (109).  
With regard to correlating lysis timing with protein accumulation for the C51 and 
A52 mutants, we determined whether early or late lysis was caused by different rates of 
synthesis for these proteins.  In prior work, systems with increased amounts of S  
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Figure 5.12.  Lysis curves of A52 (top) and C51 (bottom) missense mutants. The 
substituted amino acids are indicated beside their respective curves in corresponding 
colors.  
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Figure 5.13.  Western blot results of C51 and A52 lysing mutants.  Representative  
Western blot of protein accumulation for lysing S105 mutants (in order of increasing 
lysis time, except lanes 7 and 8, which were inadvertently switched). Lane 1: molecular 
weight marker; lane 2: A52F, lane 3: A52L, lane 4: A52Y, lane 5: C51M, lane 6: A52G, 
lane 7: C51S, lane 8: A52M, lane 9: WT, lane 10: C51N, lane 11: C51V, lane 12: C51A, 
lane 13: C51I, lane 14: C51L.  (B) Protein accumulation for S105 mutants (mutants are 
shown in the same order as (A)), as determined by densitometry from three Western 
blots.  (C) Scatter plot of protein versus lysis time for S105 mutants, as determined by 
densitometry from three Western blots.  
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protein caused earlier lysis, such as with the pQ system, which has been shown to 
accumulate more protein and lyse earlier, compared to systems with phage induction 
(109).  So, one reason for early lysis may be increased protein translation.  Samples were 
taken just minutes prior to lysis for each mutant and whole cell samples were TCA 
precipitated and analyzed by SDS-PAGE and Western blotting (Fig. 5.13).  The lytic 
mutants have varying amounts of protein accumulation prior to lysis, with early lysing 
mutants accumulating less protein and later lysing mutants accumulating more protein 
(Fig. 5.13).  The early lysing mutants seem to require a lower concentration of holin 
protein in the membrane prior to lysis.  This is opposed to a previous model which 
suggested that early lysing mutants triggered earlier because they reached a critical 
concentration of S105 more quickly than their later lysing counterparts.  In general, the 
triggering concentration of S105 is allele-specific.  
Cells which expressed S105 missense mutants, S105A52I and S105A52F were 
imaged.  S105A52I is a non-lytic allele (Fig. 5.12A), and there were no visible lesions in 
~50 cells that we imaged with cryo-EM. S105A52F, on the other hand, is an early lysing 
mutant, which triggers for hole formation at ~11 min following induction (Fig. 5.12A), 
and was shown to form inner membrane holes with cryo-EM.  The sizes of the holes in 
cells expressing the early-lysing mutant were smaller than the diameters of holes in 
S105wt cells, with the major size class being only 100 – 200 nm (Fig. 5.14).   
Prior work suggested that cells prematurely triggered for hole formation with the 
addition of an energy poison to artificially depolarize the membrane would have small 
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Figure 5.14.  Hole size distribution for cells expressing early lysing mutant S105A52F 
(red).  The sizes are compared to cells expressing S105wt (blue).  The Student‟s T-test 
was applied to this data and the following values were calculated: t-value = 5.22 and p-
value = <0.0001, indicating a significant difference between these two data sets. 
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Figure 5.15. Cryo-EM of cells with prematurely triggered holins.  (A) Number of holes 
per cell for wild-type S105 untreated (blue) and wild-type S105 + 10 mM KCN (orange). 
(B) Average hole size of prematurely triggered holins. 
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sized holes, as well.  Cells expressing S105 were prematurely triggered at 15 minutes 
post induction with 10 mM potassium cyanide (KCN) and imaged with cryo-EM.  Only 
20% of the cells had visible inner membrane lesions, and those visible holes were 
variable in size (Figs. 5.15).  The majority of the cells did not have visible lesions, which 
suggests that the holes may be so small that we were unable to visualize them with our 
current system.  As a control, cells expressing Sam7 were prematurely triggered with 10 
mM KCN at 30 minutes post induction, and 98% of the cells, or 49 out of 50, did not 
have visible lesions.    
 
Visualizing cells expressing the class I holin P2 Y.  Cryo-EM was used to visualize 
cells expressing another class I holin, P2 Y, in an effort to determine whether large 
lesions are formed.  MC4100 tonA ( Cam SR) competent cells transformed with the 
plasmid pYRamRzamRz1am were induced for expression of Y.  The cells were collected, 
concentrated, and applied to prepared EM grids, then plunge-frozen into liquid ethane to 
fix the cells in a thin layer of vitreous ice.  The cells were visualized by cryo-EM, and 65 
cells were imaged.  Fig. 5.16 shows a cell induced for expression of Y.  Of the cells that 
were imaged, 30, or 46%, had visible inner membrane lesions.  Hole size ranged from 
~114 nm to ~1.3 m, and the major size class was 200 – 400 nm (Fig. 5.17A).  In 
addition, the majority of cells with holes had a single visible hole, but there were 
instances where cells had multiple visible holes (Fig. 5.17B), and the geometry can be  
 147 
 
 
 
 
Figure 5.16.  E.coli cell expressing P2 Y.  The enlarged region shows a disruption in the 
inner membrane which is the holin-mediated lesion.  White arrows indicate the 
discontinuity in the cytoplasmic membrane. The scale bar corresponds to 0.5 m.  
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Figure 5.17.  Statistics for cells expressing Y, including hole size (A), number of holes 
per cell (B), and hole localization with respect to hole size (C).  
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used to calculate the predicted actual number of holes per cell.  As in the case of  S, Y 
holes were not localized to a specific region of the membrane, nor was there a 
correlation between hole size and localization within the membrane (Fig. 5.17C). 
 
Visualizing cells expressing class II and class III holins.  To address the question of 
whether the large lesions are characteristic of only class I holins, we imaged cells 
expressing the class II holin, S2168, and the class III holin, T4 T.  S2168 is a pinholin, so 
named because it forms very small holes in the inner membrane of its host cell (30).  A 
plasmid, containing S2168 just upstream of nonsense mutant lambda lysis genes Ram, 
Rzam, and Rz1am, was transformed into lysogenic cells containing Cam SR, and S2168 
was thermally induced for expression.  As expected, there were no visible holes in the 
inner membrane of these cells because the pinholes, which are estimated to be 1-2 nm in 
diameter (110), would be too small to be seen with our current system.  Efforts were 
made to visualize cells expressing another class II holin, 17.5 from phage T7; however, 
expression problems made this project unsuccessful.  When 17.5 upstream of Ram, Rzam, 
and Rz1am was expressed in a lysogenic strain, the holin did not trigger hole formation.     
Cells expressing the class III holin T4 T were visualized with cryo-EM in 
collaboration with Samir Moussa.  A plasmid containing T upstream of the non-
functional lambda lysis genes, Ram, Rzam, and Rz1am was transformed into the lysogenic 
strain containing Cam SR, and the T4 holin was thermally induced for expression.  
The results showed that cells expressing T did in fact have large inner membrane lesions  
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Figure 5.18.  E.coli cell expressing T4 T.  The region of the cytoplasmic membrane with 
a lesion is shown enlarged.  The arrows indicate the region of dicontinuity in the inner 
membrane.  The scale bar corresponds to 0.5 m. 
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(Fig. 5.18).  Cells expressing the Tam mutant had continuous membranes in 98%, or 50 
out of 51, of the cells imaged.  Of the 55 cells expressing T, 19, or 35%, had inner 
membrane lesions.  Hole size ranged from 99 nm to 704 nm, with the majority of lesions 
in either the <200 nm class or the 200 – 400 nm class (Fig. 5.19A).  With the current 
system, the minimum hole size visualized and measured was ~80 nm, so the smallest 
size class was actually 80 - 200 nm.  Most of the cells with holes had a single visible 
lesion, but there were instances where cells had multiple visible holes (Fig. 5.19B), and 
the geometry can again be used to calculate the predicted actual number of holes per 
cell.  Finally, the holes were located throughout the cell periphery, and there was no 
apparent correlation between hole size and localization (Fig. 5.19C). 
 
Discussion 
 The massive holes visualized in cells expressing S105 are not limited to one 
bacteriophage holin, nor to one class of holin proteins.  Instead, we have shown that the 
large lesions are present in the cytoplasmic membranes of cells expressing the class I 
holin protein Y from phage P2 and the class III holin protein T from the well-studied 
phage T4.  Over 50 cells were imaged for all holins, and the hole sizes and localization 
patterns were analyzed.  For these experiments, lysogenic strains were used and the holin 
was thermally induced.  The holes were found to be somewhat similar in size for all 
holins.  The major size class for  S105 and P2 Y was 200 - 400 nm, but with T holes, 
the major size classes were <200 nm and 200 - 400 nm.  With the current system, the 
minimum hole size visualized and measured was ~80 nm, so the smallest size class is  
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Figure 5.19.   Statistics of cells expressing T, including hole size (A), number of holes 
per cell (B) , and  hole localization with respect to hole size (C).  
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actually 80 - 200 nm.  In all cases, the holes were localized randomly throughout the 
periphery of the cell, and there was no correlation between hole size and hole location.  
Finally, in all cases, most cells with holes had a single visible hole per cell, but the 
geometry and viewing angle must be accounted for in determining the actual number of 
holes per cell because we are limited by the position and orientation of the cells on the 
grid during the freezing process.   
 Single amino acid S105 missense mutants were analyzed in terms of lysis timing, 
protein accumulation, and hole size.  The results indicated that lysis timing cannot be 
correlated with side chain size, composition, or branching pattern, nor is it the effect of 
protein translation levels.  Instead, we found that the protein concentration at the time of 
triggering is allele-specific, with early lysing mutants accumulating less protein and late 
lysing mutants accumulating more protein prior to lysis.  This conclusion is opposed to 
the former belief that early lysing mutants make more protein faster to reach the critical 
concentration necessary for hole formation.  An early lysing S105 mutant, A52F, was 
expressed in cells and shown to form lesions which were smaller in diameter than wild-
type cells. When cells expressing wild-type S105 were prematurely triggered with an 
energy poison, only 20% of the cells had visible lesions, indicating that most of the holes 
were too small to visualize with our system.       
 
Materials and Methods 
Plasmids and strains.  The plasmids used for C51 and A52 site-directed mutagenesis are 
derivatives of pS105 (2).  The plasmids used for cryo-EM were pYRamRzamRz1am, 
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pS105RamRzamRz1am (and missense mutants), pS21RamRzamRz1am, and pTRamRzamRz1am.  
All of these plasmids are derivatives of pS105 (2), and have ampicillin resistance.  The 
strains used for expression include MC4100 tonA ( Cam SR) (2) and MG1655 tonA 
lacIq lacY pQ (3). 
 
Growth conditions and monitoring. Growth conditions and TCA precipitation of whole 
cell samples for lysis curves and protein expression experiments, respectively, were the 
same as described in Chapter V, Part I. 
 
Electron microscopy.  Cryo-EM grids were prepared and imaged as previously 
described, except cultures were concentrated gently prior to liquid ethane fixation.  
Specifically, cells were vacuum filtered with a 0.45 m filter and resuspended in ~1 ml 
of LB (3).  Three to five microliters of this sample was applied to C-flat or homemade 
holey carbon grids.  
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CHAPTER VI 
 
CONCLUSIONS 
 
 
The lambda holin has been studied extensively by a combination of genetic and 
biochemical approaches over the years.  This work describes additional characterization 
of the lambda holin S105, as well as its inner membrane lesion and the lesions of other 
bacteriophage holins.  During late gene expression, the lambda holin accumulates in the 
inner membrane of its host, E. coli.  Chemical crosslinking experiments were used to 
show that the protein dimerizes and oligomerizes upon accumulation (16).  Specifically, 
non-functional missense mutants were blocked in various stages of the hole formation 
pathway.  The current model for hole formation suggests that the S105 oligomers, which 
are two-dimensional arrays or aggregates termed “rafts”, spontaneously trigger to form 
holes in the cytoplasmic membrane.  The holes allow the endolysin to pass through the 
inner membrane and degrade the peptidoglycan layer of the cell wall.  After cell wall 
degradation, the spanin proteins, Rz and Rz1, destabilize the outer membrane, and lysis 
occurs (13).  Until now, nothing was known about the structure of the holin-mediated 
membrane hole that forms during late gene expression just before phage lysis of its host 
cell.  In this work, we have visualized holin lesions for the very first time, and 
determined that they represent the largest membrane lesions ever observed, by at least an 
order of magnitude (3).  In addition, they are irregular in shape, and present in cells 
expressing at least two of the classes of holin proteins. 
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With regard to in vitro characterization of the lambda holin, this work describes 
advances in two important aspects of S105 research: in vitro reconstitution of the hole 
formation pathway and structural studies.  A completely in vitro system including 
purified lambda holin and artificial membrane vesicles would be the ideal system for 
testing the current model for S105 hole formation. Such a system has been implemented 
(1-2), and in this work, some progress was made to improve it.  The vesicles, or 
liposomes, were loaded with the self-quenching fluorophore calcein, and upon addition 
of purified S105, hole formation was assayed by an increase in fluorescence.  Using 
cysteine-less, guanidine-solubilized purified lambda holin in the fluorescence assay 
resulted in improved yields of calcein release.  
In addition to in vitro reconstitution of hole formation, structural studies of the 
lambda holin would also provide valuable information about S105 function in the lytic 
pathway.  In collaboration with the Hilty lab (Texas A&M, Chemistry Department), we 
have embarked on structural analysis of a lambda holin mutant by optimizing the 
processes involved in sample preparation and NMR assays.  In addition, TMD residues 
were shown to be involved in lipid micelle interactions, while the C-terminal tail 
residues were primarily involved in interactions with water.  These NMR studies have 
resulted in chemical shift assignments for most of the residues within the protein, and 
have provided preliminary data for obtaining structural information for the holin mutant.  
In addition, the sample preparation and NMR optimization in this work may be 
applicable to structural studies of other S105 mutants and other phage holin proteins.   
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Finally, this work has provided the first direct evidence of the inner membrane 
holin-mediated lesion.  In collaboration with Dr. Christos Savva and Dr. Andreas 
Holzenburg (Texas A&M, MIC), we used cryo-EM to visualize cells expressing the 
following holins: lambda S105, P2 Y, S2168, and T4 T.  Large holes were imaged in the 
cytoplasmic membranes of cells expressing the class I holins S105 and Y, as well as the 
class III holin T.  The S105 holes were much larger than anticipated with an average 
diameter of ~340 nm (3).  Most of the cells with holes had only a single visible lesion, 
but multiple holes per cell were seen in some cases.  The geometry, together with the 
viewing angle, can be used to determine the actual number of holes per cell since the 
number of visible holes is limited by the position and orientation of the cells on the EM 
grid.  In addition, the holes were localized randomly throughout the membrane, and 
there was no correlation between hole localization and hole size.  Cryo-electron 
tomography was also used to create three-dimensional reconstructions of the S105 
membrane hole, providing information on the overall extent of hole formation and the 
somewhat irregular shape of the hole (3). 
The holin-mediated lesions described in this work were extremely large.  In fact, 
the average hole size was ten-fold greater than the largest known membrane channels in 
biology, the cholesterol-dependent cytolysins (3, 21-22).  Why are the holes so big?  One 
answer to this question may be considered in an evolutionary context.  Consider, for 
example, the bacterial holin encoded by tcdE, which is found in Clostridium difficile 
(111).   This particular holin gene is located between two toxin genes called tcdA and 
tcdB.  These toxin genes encode two of the largest known bacterial toxins (112), with 
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TcdA and TcdB being 308 kDa and 269 kDa in size, respectively (113).  Interestingly, 
these two proteins do not have signal sequences (111, 114), so there is no obvious 
pathway for their extracellular release, except lysis.  Since these proteins are so large, it 
has been hypothesized that TcdA and TcdB may exit the cell via the TcdE holin lesion 
(111, 115).  In this context, the inner membrane hole must be large enough to 
accommodate these massive proteins.             
The current model for S105 function suggests that a lesion spontaneously forms 
in the cytoplasmic membrane of E.coli from a two-dimensional aggregate, or raft, at the 
triggering time.  The timing is allele-specific and the critical concentration of S105 
molecules in the membrane at the triggering time is also allele-specific, such that early 
lysing mutants have less protein in the membrane at the time of lysis, and later lysing 
mutants have more protein in the membrane at the time of lysis.  There is biological 
precedence for such an allele-specific critical concentration model which involves the 
integral membrane protein bacteriorhodopsin, or BR.  This protein, together with lipid, 
forms the two-dimensional lattice purple membrane of Halobacterium salinarum (116-
117).  BR has seven -helical TMDs, and was used to study membrane protein 
oligomerization.  Mutations were made at the residues involved in helical interactions 
within the oligomerized protein complex, and the stability of the BR-lipid lattice was 
assayed for the mutant proteins.  In each case, the mutants either increased or decreased 
the stability of the lattice (116).  In other words, there was an allele-specific effect which 
resulted in changes in the self-assembly of BR in the membrane. 
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According to the current model, the S105 raft reaches a critical concentration, 
after which the protein undergoes conformational changes leading to hole formation and 
dissipation of the pmf.  Therefore, the holin critical concentration and subsequent timing 
of lysis are directly related to protein interactions in the membrane.  This model infers 
that individual phage holins would have different intermolecular interactions and 
therefore, different critical concentrations.  In addition, the timing of hole formation and 
lysis would vary among these holins.  However, a surprising result showed that lambda 
S and T4 T holins are additive, i.e. when these holins were co-expressed, lysis occurred 
sooner than when they are each expressed alone (34).  Since S and T do not share any 
sequence similarity, it is unlikely that these two proteins interact to form rafts and holes 
together.  In addition, there is no effect on the membrane potential prior to the instant of 
triggering for lysis (38), indicating that the pmf remains intact and is not titrated out by 
oligomerized holins.  Instead, there may be a host inhibitory protein blocking hole 
formation.  Prior to this shocking result of the additive hole formation by S and T (34), 
the host inhibitory protein model seemed unlikely given the diversity of holins and their 
function in both yeast and mammalian cells, but it cannot be excluded as a possibility.   
   The phage-shock-protein, or Psp, functions in extracytoplasmic stress response 
(118), and may be an example of a host protein that inhibits hole formation.  These 
proteins are common to many types of bacteria, including E. coli, and in many bacterial 
genomes, there are two or more adjacent Psp proteins which together comprise a Psp 
system (118).  It is believed that dissipation of the membrane pmf is an inducing signal 
for the Psp system.  Therefore, these proteins may be induced after holin lesion 
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formation, which is accompanied by depolarization of the membrane.  In this context, 
the Psp system would serve to counteract the dissipation of the pmf, thus prolonging 
lysis timing.  In the example above where S and T are co-expressed, lysis may have 
occurred earlier because there was simply not enough Psp to block hole formation by 
both functional holins.  
The formation of S105 rafts was visualized by Dr. Rebecca White when she 
expressed S105-GFP in cells and imaged them with fluorescence microscopy (109, 119).  
Prior to the triggering time, S105-GFP was localized throughout the membrane of the 
cells, and after the triggering time, there were punctuate spots, or patches, of 
fluorescence in specific regions of the membrane.  Correlative microscopy is currently 
underway to co-localize the S105-GFP rafts visualized with fluorescence microscopy 
and the membrane holes visualized with cryo- EM.  Currently, there is no direct 
evidence that S105 is lining the holes, or lesions, although the current model suggests 
that is in fact the case.  Co-localization of the protein around the edges of the membrane 
hole would provide indisputable evidence that the lesions we have visualized here for the 
first time are a direct result of S105 accumulation in the membrane.   
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